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Abstract
Dental caries is considered to be one of the most prevalent infectious disease in humans
across all age groups because they affect 60-90% of the world’s population. With the
introduction of refined sugar into the modern diet and an improved understanding of the
pathogenesis of dental caries, the need for novel approaches to caries prevention has become
is a key undertaking for addressing the caries burden in the 21st century. While previous studies
have shown successful elimination of bacteria in the oral cavity, only a few modalities such as
antimicrobial peptides, vaccines and more recently, nanoparticles, have been developed to
specifically target Streptococcus Mutans. Here, we discuss the significance of the biofilm and
the essential role of Strep. mutans in the development of dental caries. We focus on current and
prospective therapeutic approaches against dental caries, including chemical modalities such as
fluoride and chlorhexidine, vaccines, antimicrobial peptides, replacement therapy, quorum
sensing targets, nanoparticles and natural products. Further research is needed to develop a
safe and efficacious approach against caries, or specifically Streptococcus Mutans, in humans.

I.

Discussion of National and Worldwide Burden of Caries
3

Dental caries is one of the most common childhood diseases. It is estimated that
over 90% of the world’s population will experience dental caries at least once during
their lifetime (Marchisio 2010). Dental caries is considered to be one of the most
prevalent infectious disease in humans across all age groups because they affect 6090% of the world’s population (Petersen 2005).

Oral diseases and disorders affect health and well-being throughout life.
According to the Oral Health in America: A Report of the Surgeon General in 2000,
dental caries is the single most common chronic childhood disease - 5 times more
common than asthma and 7 times more common than hay fever. Over 50% of children
5-9 years old have at least one cavity or filling and that proportion increases to 78%
among 17 year olds and 84.7% for adults 18 or older. Additionally, 49.7% of people 75
years or older had root caries affecting at least one tooth (NCHS 1996, NHANES III). By
age 17, more than 7.4% of US children have lost at least one permanent tooth because
of caries; by age 50, Americans have lost an average of 12.1 teeth, including third
molars. Dental caries is one of the primary causes of tooth loss among adults.

The social impact of oral diseases is substantial in children, amounting to more
than 51 million school hours lost each year due to dental-related illness. Disparities in
dental disease can be attributed to socioeconomic status. (Surgeon General’s Report
2000). More than 1/3 (36.8%) of poor children aged 2-9 have one or more untreated
decayed primary teeth, compared to 17.3% of non-poor children. Furthermore, the
proportion of teeth affected by dental caries also varies by age and race/ethnicity. Poor
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children from Mexican-American or non-Hispanic black backgrounds are at a higher risk
group, with over 2/3 of this population having untreated decayed teeth. (NCHS 1996).

In the African American population, “baseline data for the Healthy People 2010
objectives established that for children aged 2 to 4 years, 24.0 percent of non-Hispanic
blacks have experienced dental caries in their primary teeth, compared to 15.0 percent
for their non-Hispanic white counterparts.” (Surgeon General’s Report 2000). In the
Asian and Pacific Islander American (APIA) population, “there is variation in oral health
status among subgroups of children. In a recent survey in Hawaii, the prevalence of
early childhood caries among APIA children was 16 percent, ranging from a low of 8
percent among Japanese children to a high of 25 percent among Filipino children. The
prevalence of untreated dental caries in 6- to 8-year-old APIA children was 39 percent,
which ranged from a low of 16 percent among Japanese children to 40 percent among
Native Hawaiians, 48 percent among Southeast Asians, and 62 percent among nonNative Hawaiian Pacific Islanders (Greer 1999). (Surgeon General’s Report) In the
Hispanic group, “preliminary data from NHANES III indicate that young Mexican
American children aged 2 to 4 are more likely to have experienced dental caries in their
primary teeth, have on average more decayed and filled tooth surfaces, and have more
untreated disease than either non-Hispanic white or non-Hispanic black children (Kaste
et al. 1996). Mexican American children aged 2 to 5 years—especially those from lowerincome households—were more likely than their African American and non-Hispanic
white counterparts to have one or more decayed primary teeth (Vargas et al. 1998). A
national survey found that employed Hispanic adults were twice as likely to have
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untreated dental caries as non-Hispanic whites.(Watson and Brown 1995)” (Surgeon
General’s Report 2000)

Healthy People 2020 has focused on 2 leading evidence-based interventions to
prevent tooth decay: 1) Community water fluoridation and 2) School-based dental
sealant programs. Community water fluoridation is an effective, safe and ideal public
health measure which benefits individuals of all ages and socioeconomic status. Studies
show that it can reduce tooth decay by 18-40%. However, over one third of the US
population (100 million) do not currently benefit from this measure. (Surgeon General’s
Report 2000). According to statistics from the Centers of Disease Control in 2013, over
70% of US residents who rely on community water systems receive fluoridated water.
CDC recognizes community water fluoridation as 1 of the 10 great public health
achievements of the 20th century.
School-based dental sealant programs usually target schools that serve children from
low-income families. Dental sealants can prevent up to 60% of tooth decay in the
treated teeth. (Ahovuo-Saloranta A et al 2013). Thirty six states reported dental sealant
programs serving 258,000 children. This represents only about 8% of lower income
children who could receive sealants. Currently used strategies for caries prevention
such as oral health education, chemical and mechanical plaque control, use of fluorides,
application of pit and fissure sealants are mostly broadly effective. (Surgeon General’s
Report 2000)
According to the World Health Organization’s Report on ”Oral health: action plan
for promotion and integrated disease prevention” in May 2007, future action calls for
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further support for building at the national and community level, and implementing
comprehensive and integrated oral-health programs, particularly in low and middle
income countries and for poor and disadvantaged groups. In developing countries,
dental caries remains in epidemic proportions. An oral health survey conducted in China
revealed that 3 out of 4 5-year old children had evidence of significant dental decay.
(Wong et al 2001). More effective public health measures are necessary to address this
worldwide problem.

II. Understanding the Complexity of Biofilms
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While the pathogenesis of dental caries is complex, it often begins with
cariogenic bacteria entering the dental biofilm at the early stages of life and
subsequently emerging, under favorable environmental conditions to cause disease.
(Smith 2002). In 1993, the term “Window of Infectivity” was coined by Caufield to
describe the observation that children become permanently colonized with
Streptococcus mutans between the middle of their second year and the end of the 3rd
year of life under normal diet and environmental challenge. If infants fail to acquire
Streptococcus mutans (MS) during this period they are unlikely to be colonized until
around 6 years of age when the permanent molar teeth erupt. The higher the level of
maternal strep mutans, the higher the percentage of children who become infected.
(Kohler et al 1984). Though studies have shown that the primary source of infection is
maternal, a few studies have also suggested that non-familial transfer can occur when
the environmental conditions favor colonization (Mattos-Graner et al 2001). One of the
most important virulence factors of cariogenic bacteria is their ability to adhere to oral
surfaces and the colonization of subsequent bacteria to create biofilms.

Biofilms are complex microbial communities. A recent report using
pyrosequencing analysis estimated the number of phylotypes in the oral cavity to be
greater than 19,000 (Keijser et al 2008). This matrix consists mainly of hydrated
polysaccharides, proteins, glycopeptides, extracellular DNA and lipids (Dong et al
2002). A biofilm is usually polymicrobial, consisting of multiple organism species such
as fungi, bacteria and viruses that exist at a phase or density interface, and encased in
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a self-secreted extracellular matrix. The extracellular matrix which surround the bacteria
reduces penetration of antimicrobial agents into the deeper layers of the biofilm.
Cohabitation of multiple organisms not only creates competition for space but also
promotes cooperative interactions such as horizontal gene transfer, metabolic
cooperation and other synergies. This enhances the “survivability of microorganisms
and resistance to antimicrobial agents” (Yang et al 2011; Wolcott et al 2013).

Since the biofilm responds as a community rather than as an assemblage of
individual cells, cell-to-cell coordination, communication and signaling are imperative.
Quorum sensing, the secretion and detection of a diffusible molecule by the community
members can lead microbial species to suddenly change their behavior. One example is
production of virulence factors (Remis et al 2010). There are 3 physiological properties
of the biofilm that makes it an effective barrier that is difficult to overcome with
therapeutics. (Hoiby et al 2010, Mah et al 2012) Firstly, there is a delayed or reduced
penetration of any antimicrobials due repulsion and/or sequestration by the
exopolysaccharide matrix. Secondly, the presence of metabolically inactive “persister”
cells that are able to survive antimicrobial attacks, preventing complete elimination of
the colony. Thirdly, due to close proximity of other cells, there is an increased possibility
of exchange of mobile genetic elements encoding resistance. When cells exist in a
biofilm, they can become 10-1000 times more resistant to the effects of antimicrobial
agents. (Mah et al 2012) This presents a challenge in treatment targeting cariogenic
bacteria which reside in the oral biofilm.
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The molecular pathogenesis of biofilm formation involves several phases. A
saliva film containing albumin, glycoproteins, acidic proline-rich proteins, mucins, silica
acids, and other compounds cover the tooth surface. This film called the acquired
pellicle, provides receptors for the initial colonizers (Kreth et al 2009). Initial attachment
to the tooth surface is achieved via interaction of bacterial proteins with lectins in the
dental pellicle covering the tooth surface. (Smith et al 2002) Streptococcal adhesins,
also known as antigen I/II or PAc in Strep mutans, bind to salivary components in
experimental dental pellicles. The accumulation phase of acidogenic streptococci is
then initiated by the activity of extracellular glucosyltransferases (GTF). Specifically
GTF-B and GTF-C have been found to synthesize insoluble forms of glucan which is
most closely associated with pathogenicity. In the presence of sucrose, GTFs
synthesize several forms of high-molecular weight branched extracellular glucans.
These glucans act as a scaffold for the aggregation of Strep mutans or other bacteria
through the interaction with bacterial cell-associated glucan-binding domains of GTFs
and Glucan Binding Proteins (GBPs). The succession of biofilm development involves
congregation and coadherence of oral bacteria, and if undisturbed, develops into a
stratified, complex biofilm. (Kreth et al 2009) The last phase of pathogenesis is the
production of lactic acid, a bacterial metabolic end product, which results in the erosion
of hydroxyapatite-like mineral in dental enamel. It is critical to understand the intricacies
of the dental biofilm in order to understand possible targets for anti-caries intervention.

The initial colonization process is dominated by oral streptococci, which make up
over 80% of the early biofilm constituents (Rosan and Lamont, 2000) Current
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approaches to biofilm control include either a therapeutic focus, with elimination of
mature biofilms or a prophyolactic focus, preventing biofilm development by killing
planktonic cells, disrupting their adhesion to a surface or inhibiting growth of attached
cells in the early biofilm stage (Jorge et al 2012). Strep mutans fuse with dental
pellicles via 2 independent mechanisms: sucrose-dependent and sucrose independent.
The sucrose dependent pathway involves the expression of antigen I/II (Mitchell 2003)
and a virulence factor which binds the glycoprotein which coats teeth, salivary
agglutinin. The sucrose independent pathway is more efficient and depends on glucans
for attachment to the tooth surface. GTFs B, C and D produced by Strep. mutans
convert sucrose to glucans.

III. Historical Perspective of Cariogenic Bacteria
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W.D Miller first proposed the acid decalcification theory of dental caries in 1890.
This theory involved 2 steps. Firstly, acid is produced from fermentable carbohydrate by
bacteria in the mouth. Secondly, the acid dissolves tooth mineral resulting in a cavity.
Miller considered that all bacteria in the mouth were potentially cariogenic, a concept
now known as the “non-specific plaque hypothesis”.

In 1986, Loesche coined “specific/non-specific plaque hypothesis” for dental
caries. The specific plaque hypothesis stated that Strep mutans is the primary cause of
dental caries and treatment should be directed toward its elimination. The non-specific
plaque hypothesis on the other hand stated that treatment of caries should be directed
toward the correction or compensation of any oral microbiota imbalance. Bacteria are
necessarily secondary and the promotion of oral bacteria that produce alkali is crucial.
Additionally, the non-specific plaque hypothesis suggests that oral bacteria as a whole
produce acid from fermentable carbohydrates. Therefore, the removal of as much
plaque as possible is the appropriate treatment in dealing with caries.

While Clarke first isolated Strep mutans from carious lesions in 1924, it was a
keystone study by Fitzgerald and Keyes in 1960, where direct evidence for involvement
of specific microorganisms in dental caries was observed in albino hamsters. These
hamsters only developed caries when caged together with other “caries-active
hamsters”. This showed that specific microorganisms were involved in the induction of
dental caries and that the disease was transmissible. Several studies led to the
discovery of at least 8 serotypes of Strep mutans, which were grouped mainly into 4
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species relevant to humans and small laboratory animals. Serotypes c, e and f
remained Strep mutans. Serotype c Strep mutans strains are most frequently isolated
from the human oral cavity (Loesche 1986) Serotype d, g and h became Strep sobrinus.
Serotype a became Strep cricetus and serotype b became Strep rattus. Collectively,
they are referred to as Mutans Streptococci (MS). Strep mutans and Strep sobrinus the
are the most important in dental caries. In addition to Strep mutans, Lactobacilli have
also been found to have an associative relationship with caries development. (Kleinberg
2002) Though not essential in the caries process, lactobacilli have been found in sites
favoring retention of fermentable carbohydrates or sites with dental appliances such as
orthodontic bands. These sites have an elevated count of Lactobacilli and more
acidogenic dental plaque.

In 2002, Kleinberg proposed the “mixed-bacterial ecological approach” as
another model for caries development. This approach suggests that the proportion of
acid-base producing bacteria is key in dental caries. Manipulating the proportion of
arginolytic and non-arginolytic bacteria in the oral cavity changes the level of caries
activity in an individual. Two landmark studies by Stephan in 1940 and 1944
demonstrate that dental plaque produced rapid and substantial decreases in the pH in
vivo. pH would substantially decrease following a sugar challenge and then slowly rise
to baseline over an hour. The effects of saliva on the Stephan pH curve was studied. In
the presence of saliva, there was a fall in pH to a minimum, then a subsequent slow rise
toward baseline. In the absence of saliva, pH dropped significantly and then remained
at a lower level for much of the experimental period. The rise part of the Stephan curve
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was lost in the absence of saliva, possibly due to the absence of salivary bicarbonate
(Wijeyeweera et al 1989). Through fractionation experiments, Kleinberg identified the
pH-rise factor in saliva as arginine. Arginolytic bacteria produce base from arginine.
Major acidogenic bacteria are non-arginolytic; they produce a pH fall but little or no pH
rise. Other acidogenic bacteria also produced a pH fall but one that was less, because
these bacteria produce base from arginine (arginolytics). Bacteria in plaque that are
able to raise the pH by degrading arginine and producing base would be expected to
produce less net acid and consequently be less or non-cariogenic. All Strep mutans are
non-pH rising except Strep rattus, an arginolytic bacteria which has been associated
with a caries free condition in both animals and humans (Kilian et al 1979). According to
Kleinberg’s mixed- bacterial ecological approach, the ratio of arginolytic to nonarginolytic bacteria is a key factor in the cariogenicity of the Stephan curve. A higher
ratio is correlated with a less cariogenic Stephan pH curve whereas with the reverse a
more highly cariogenic type of curve. A deficiency in base formation due to lack of saliva
or a lower ratio of arginolytic to non-arginolytic bacteria can have similar cariogenic
effects as an increased acid formation from a diet high in carbohydrates or a greater
ratio of arginolytic to non-arginolytic bacteria.

IV. Focus on Mutans Streptococci and its Virulence Factors
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MS possesses certain properties that enable them to predominate in dental
plaque. The characteristics are: extracellular polysaccharide synthesis, acidogenicity
(acid production), aciduricity (ability to survive in an acidic environment), intracellular
polysaccharide (ICP) synthesis and endodextranase production. ICP is produced by
some MS in the presence of carbohydrates. When carbohydrate is depleted, ICP can be
metabolized leading to continued acid production. Studies of mutant Strep mutans
which do not have the ability to produce ICP, while able to colonize teeth of rats, are
relatively less cariogenic then non-mutant strains. Strep mutans is a key contributor to
the polysaccharide rich extracellular matrix due to the production of glucans by three
Gtfs: Gtf B synthesizes mainly insoluble glucans with alpha (1-3) glycosidic linkages, Gtf
C synthesizes a mixture of insoluble and soluble glucans and Gtf D synthesizes
predominantly soluble glucans with alpha (1-6) linkages. Gtf B and Gtf C are associated
with the initial microbial adherence and structural stability of the extracellular matrix.
GtfC has the greatest affinity for the hydroxyapatite surface, followed by Gtf B and Gtf
D. (Koo 2010) A Gtf-targeted inhibitor can disrupt the formation of capsular-like glucans
which make up the biofilm. Since this extra polysaccharide glucan matrix protects the
microorganisms from antimicrobial agents, inhibiting glucan synthesis will allow
substances such as fluoride or chlorhexidine to better penetrate the biofilm and
enhance their biological efficacy. Another advantage of a Gtf-inhibitor is its ability to
affect biofilm formation without directly killing bacterial cells. Poor biofilm formation is
due to reduced adherence rather than cell death (Ren 2015). In this recent study, the
author identified novel molecules that target Gtfs in order to inhibit Strep mutans biofilm
formation. Structural based screening of approximately 150,000 commercially available

15

compounds was performed against the crystal structure of the substrate binding domain
of the GtfC protein from Strep mutans. This resulted in the identification of a quinoxaline
derivative 2-(4-methoxyphenyl)-N-(3{[2-(4-methoxyphenyl)ethyl]imino}-1,4-dihydro-2quinoxalinylidene) ethanamine as a potential Gtf inhibitor. This study suggests that a
reduction in biofilm formation may be a better strategy to control caries formation as it
does not disturb the remaining oral microbiota.

A study by Koo et al 2010 reported on the role of the Strep mutans gtf genes in
development of micro colonies and the exopolysaccharide biofilm matrix. Mutants
defective in gtfB and C genes showed a loss of ability to synthesize exopolysaccharide
matrices, adversely affecting the development of micro colonies. GtfB and Gtfc also
produce glucans which enhance the ability of Strep mutans to persist on apatitic
surfaces and out compete other oral species. It has been suggested that micro colony
development may be linked to bacterial virulence, therefore, this glucan-dependent
mechanism has a significant effect on the survival of Strep mutans in complex biofilms.
Development of the exopolysaccharide matrix and subsequent acidic niches has
significant biological importance, creating shifts in the microbial population. As the
environment becomes more acidic, Strep mutans have the ability to upregulate several
stress survival pathways. GtfB, GtfC and glucan-binding proteins are further induced,
leading to increased biofilm accumulation and colonization of other cariogenic species,
such as Lactobacilli. This new environment provides a competitive advantage for all
types of aciduric and acidogenic microflora. Consequently, these niches protected by a
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diffusion-limiting polymeric matrix results in a biofilm that is recalcitrant to antimicrobials
and a challenge to disrupt. (Koo et al 2013)

Another study by Li et al 2010 showed that when Strep mutans were added to
saliva biofilms that were allowed to grow for 16 hours, there was a 9 +/-0.4 (SD) fold
reduction in Strep mutans incorporated into the biofilms as compared to Strep mutans
inoculated with other bacteria and allowing the biofilm to form. This suggests that there
is a protective colonization effect of a biofilm prior to addition of Strep mutans.

V. Current and Prospective Therapeutic Approaches Against Dental Caries
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A. CHEMICAL MODALITIES - FLUORIDE, CHLORHEXIDINE

Despite fluoride being the most effective anti-caries agent today (Clarkson,
2000), dental caries remains a public health problem among underprivileged
populations around the world. Numerous studies have investigated the effects of
fluoride and chlorhexidine, both routinely used in clinical practice today, on caries
development. Although fluoride’s effect on remineralization is well known, it also has
important effects on bacteria in dental plaque (Marquis 1995). Fluoride acts directly to
inhibit glycolytic enzyme enolase. Fluoride also enhances membrane permeability to
protons and compromises the functioning F-ATPases in exporting protons. This induces
cytoplasmic acidification and acid inhibition of glycolytic enzymes. (Marquis 1995).
Fluoride reduces the acid tolerance of bacteria and is most effective at acidic pH values.
Fluoride can prohibit glycolysis in Streptococcus mutans in acidic conditions. The
anticaries effect of fluoride not only consists of remineralization but also inhibition of
acidogenic bacteria in acidic conditions.

In an in vitro study by Savas 2015, the potency of 5 different substances, 1) 38%
Silver Diamine Fluoride 2) Acidulated phosphate fluoride (APF) 3) Ammonium
hexafluorosilicate (AHF) 4) Ammonium hexafluorsilicate + cetylpyridinium chloride (AHF
+ CPC) and 5) 0.2% chlorhexidine - were tested in reducing the number of viable
microorganisms in biofilms. The number of viable bacteria was significantly reduced by
all of the antibacterial agents. However, silver diamine fluoride (SDF) showed the
highest antibacterial activity, with no viable microorganisms detected, while the
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effectiveness of the other agents were lower. Another study also reported that after
treatment of mature Strep mutans biofilms with SDF, the bacterial count decreased to
zero (Chu et al 2012) SDF contains high concentration of silver (253,870ppm) and
fluoride (44,800 ppm) ions. Silver ions are bactericidal metal cations that inhibit biofilm
formation by inactivating and interfering with bacterial synthesis of cellular
polysaccharides through inactivation of the glucosyltransferase enzymes responsible for
the synthesis of soluble and insoluble glucans.

In a more recent study, a newly developed nano silver product was tested and
evaluated for its antimicrobial and cytotoxicity activity against Strep. mutans. This
product, known as nano silver fluoride (NSF), is a combination of silver nanoparticles
and chitosan (Santos Jr VE 2014). From previous studies, it was noted that the
antibacterial activity of silver nanoparticles increases as the particle size decreases.
Chitosan is a biocompatible, biodegradable and non-toxic biopolymer obtained by the
deacetylation of chitin. It has antibacterial activity against a broad spectrum of bacteria,
including Strep mutans and Strep sanguinis (Targino 2014). The results from this study
revealed that NSF may be effective against Strep mutans at much lower doses, does
not stain teeth and may have lower toxicity than SDF. The biological effects and
mechanism of action of fluoride has been well documented in a paper by Koo 2008. The
paper discussed 2 major effects of fluoride on microbial cells: 1) direct inhibition of
enzymes in cells, either directly of in the form of metal complexes (Marquis et al 2003)
and 2) increasing proton permeability and acting as a transmembrane proton carrier.
Fluoride inhibits the release of protons via F-ATPases by moving protons back into the
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cell via HF. The cell is 10^7 times more permeable to HF then to F- (Marquis 2003). In
the cytoplasm, HF dissociates to H+ and F- and the increased acidity inhibits glycolytic
enzymes. Most chemotherapeutic strategies to enhance the biological activity of fluoride
are based on the use of broad-spectrum antimicrobials, such as chlorhexidine, triclosan
and metal ions/cations which also suppress resident flora (Koo 2008)

Several studies by Koo et al (2002, 2003, 2005) reported on strategies to
enhance the biological effects of fluoride on dental biofilms. Apigenin and tt-farnesol,
two naturally occurring compounds, have demonstrated anti-cariogenic activity against
Strep. mutans in vitro and in vivo. Apigenin inhibits GTF-B and GTF-C and affects the
expression of gtfB and gtfC genes, which are responsible for the synthesis of insoluble
glucans. tt-farnesol disrupts the proton permeability of Strep. mutans membrane,
inhibiting acid production and glucan synthesis by Strep mutans (Koo et al 2003, 2005).
Topical application of apigenin and tt-farnesol reduced the incidence of dental caries
with minimal effects on the viability of resident microflora in rats (Koo et al 2003). The
combination of 1mM apigenin and 5mM tt-farnesol with 250-ppm fluoride was the most
effective in reducing the biomass, polysaccharide content and acidogenicity of biofilms
(Koo et al 2005).

Chlorhexidine (CHX) is still the most frequently used antimicrobial for reduction of
plaque for caries control due to its broad antimicrobial spectrum. However,
chlorhexidine rinse has been approved for use to reduce gingivitis but not for caries
prevention (Vollmer 2010). A study conducted in 2000 using a 10% chlorhexidine
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varnish on adults with low salivary flow rates suggested a significant difference in
varnish and placebo treatments on root caries (41% reduction) and total caries
increment (25% reduction) (Banting 2000) In the study by Savas 2015, a single
application of CHX was found to have significantly lower bactericidal activity compared
to other agents such as SDF. Another study reported that a five-minute application of
0.2% CHX did not significantly reduce the viability of microorganisms, however, a 60
minute treatment resulted in a marked reduction in bacterial viability (Pratten et al
1998). Another study reported that 0.2% CHX had an effect in inhibiting Strep mutans in
6 hr biofilms, however its effect was limited to the outer layer of 48 hr dental plaque
(Zaura-Arite et al 2001). Similarly, another study reported the application of 0.1% CHX
for 1 or 5 min did not have a sufficient effect on 24 hr oral biofilm (Vitkov et al 2005).

B. VACCINES
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Early studies of dental caries performed in rats employed whole cells of strep
mutans as a possible vaccine (McGhee et al 1975). Later studies focused on vaccines
manufactured from various cell-surface antigens of strep mutans and their recombinant
fragments or synthetic peptides (Koga et al 1995, Kuramitsu, 1993). Animate
(attenuated bacterial factors) and inanimate (liposomes, microparticles) delivery
systems have been shown to provide efficient targeting of the vaccine. Both passive
and active immunization approaches in animal models and human clinical trials have
showed success in delaying the recolonization of Strep mutans.

Molecular targets that have been studied in dental vaccines consists of: 1)
blocking receptors necessary for colonization (ex. Adhesins), 2) blocking receptors
necessary for accumulation (ex. glucan-binding domains of GBPs and GTFs), 3)
inactivating GTF enzymes responsible for glucan formation and 4) enhancing
antimicrobial activity of salivary IgA or redirecting synergism with innate components of
immunity such as mucin or lactoferrin. Strep mutans adhesins have been identified as
antigen I/II, PAc or P1 and are responsible for initial attachment of bacteria to tooth
surfaces. There has been abundant in vivo and in vitro evidence to indicate that
antibodies with specificity for Strep mutans PAc can interfere with bacterial adherence.
PAc in different forms, as a full-length protein, recombinant or synthetic peptide (Smith
2005), protein-carbohydrate conjugate (Wachsmann et al 1986) or DNA based active
vaccines (Xu 2007), has been tested in experimental systems and proven as an
effective immunogen. Glucosyltransferases produce soluble and insoluble glucans from
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sucrose. Antibodies directed to native GTF or sequences associated with its catalytic or
glucan-binding function disrupts the synthetic activity of the enzyme and consequently
inhibit in vitro plaque formation (Smith et al 1978). Glucan binding proteins (GBPs) bind
alpha-1,6-glucan and provide receptors for glucan-mediated aggregation in biofilm
development. A study conducted in 1996 by Smith and Taubman in rats injected
GBP59, glucosyltransferase (GTF) or phosphate buffered saline (sham) twice at 9-day
intervals subcutaneously in the salivary gland vicinity with, with an adjuvant. Two weeks
after the second injection, GBP59 and GTF injected rats contained significant levels of
salivary IgA and serum IgG to the respective injected antigens. Rats were then infected
orally with Strep mutans. Following 71 days of infection, GBP and GTF-injected groups
had fewer Strep mutans on their molar surfaces compared with sham-injected infected
groups. This suggests that immunization with Strep mutans GBP59 and GTF in rats
induces an immune response upon future exposure to cariogenic streptococcus.

Active immunization and passive immunization against dental caries have been
extensively documented in the literature. Many active immunization studies demonstrate
the important anti-caries role of salivary IgA (Russell et al 1999). Salivary IgA is
essentially absent at birth but the oral immune environment undergoes rapid
development early in life. Mature salivary IgA is the principal salivary immunoglobulin
secreted by individuals at 1 month of age, in addition to considerable concentrations of
IgM. By 6-9 months, most children exhibit a more adult-like distribution of salivary IgA1
and IgA2 subclasses (Smith et al 2002). By the second or third year of life, immune
responses to streptococcal components such as antigen I/II, glucosyltransferase and
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glucan-binding proteins are present and play a role in the ultimate colonization and
accumulation of Strep mutans. Several studies have shown that mucosal exposure of
humans to gluocosyltransferases of Strep mutans or Strep sobrinus can lead to
formation of salivary IgA antibodies (Smith 2002). Five of 7 adults who were orally
immunized using enteric coated capsules filled with Strep mutans GS-5 GTF antigen
preparations contained in liposomes, had increased levels of parotid salivary IgA
antibodies, primarily of the IgA2 subclass (Childers 1994).

Mucosal immunization with GTF could also influence the emergence of Strep
mutans in young adults after dental prophylaxis. Young adults were given S. sobrinus
GTF administered together with aluminum phosphate topically to the lower lip daily for 5
days. Post dental prophylaxis, there was a delay in re-accumulation of indigenous oral
mutans strep, compared with the placebo group given buffer-filled capsules. (Smith and
Taubman 1987, 1990). Young adults between 18-42 years of age were screened for
levels of antibody activity to GTF in parotid and labial gland salivas and levels of Strep
mutans in their whole saliva. Prior to antigen administration, both active and placebo
group had similar distributions of Strep mutans in their whole saliva. Although there was
no statistical significant difference in anti-GTF IgA antibody activity in parotid or labial
salivas between GTF-administered and placebo groups during the 6 weeks following
topical application, the proportion of indigenous Strep mutans/total strep flora or total
cultivable flora were always lower in whole salivas of the subjects immunized with GTF,
compared with placebo. Delays in reaccumulation of microflora was significantly
associated with elevations in parotid saliva IgA levels. (Smith and Taubman 1987, 1990)
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Passive immunization was tested in earlier studies using mouth rinses containing
bovine milk (Filler et al 1991) or hen egg yolk IgY antibody (Hatta et al 1997) to Strep
mutans. These studies led to modest short-term decreases in the numbers of
indigenous strep in saliva or dental plaque. The effectiveness of a mouth rinse
containing antibodies to Strep mutans in preventing the establishment of the bacteria in
dental plaque was tested. Immune IgY inhibited Strep mutans adherence to salivacoated hydroxyapatite discs by 59.2%, while control IgY caused an inhibition of only
8.2%. In the short-term (4-hour) test using a mouth rinse containing 10% sucrose,
immune IgY decreased the ratio of the percentage of Strep mutans per total
streptococci in saliva. with regards to the ratios of the percentage of Strep mutans per
total streptococci in plaque of individual subjects, there was a tendency for a reduction
of the ratios in the volunteers receiving the mouth rinse containing immune IgY. These
results support the effectiveness of IgY with specificity to Strep mutans grown in the
presence of sucrose as an efficient method to control the colonization of mutans
streptococci in the oral cavity of humans.

A study by Ma et al in 1990 examined the long-term effects on indigenous
microflora after topical application of mouse monoclonal IgG or transgenic plant
secretory Secretory IgA/G antibody, with specificity for AgI/II. Subjects’ teeth were
treated for 9 days with chlorhexidine, then antibody was topically applied for 3 weeks.
The group treated with mouse monoclonal IgG did not experience recolonization with
mutans for at least 2 years after treatment and the group treated with transgenic
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antibody to the Ag I/II epitope did not experience recolonization for at least 4 months.
Subjects who were treated with non-specific monoclonals had strep mutans
recolonization within 82 days. No clinical side effects were reported in any of the
subjects that received monoclonal antibody and there was no evidence of serum,
salivary or gingival fluid antibody responses against the antibody. Other studies on
experimental passive immunization demonstrated that protection could also be
achieved with antibody to GTF (Hamada 1991) or GBP (Smith 2001).

Immunization via intranasal and oral routes have also been reported in previous
studies. Mucosal application is generally preferred for induction of salivary IgA since
mucosal IgA immune responses are most efficiently induced by administration of
vaccines onto mucosal surfaces. The oral route is not ideal because the acidic stomach
environment can diminish the effective antigen stimulus before uptake in the GALT (gut
associated lymphoid tissue). Intranasal vaccination elicits both humoral and cell
mediated antigen-specific immune responses and also requires a much smaller dose of
antigen than oral vaccination for induction of antigen-specific mucosal and systemic
immune responses. However, in order to develop an effective nasal associated
lymphoid tissue (NALT) targeted vaccine delivery system, an adjuvant is necessary. A
study that included salmonella-derived protein at the time of pGJA-P/VAX
administration resulted in an enhanced IgA and serum IgG antibody response (Shi et al
2012). Flagellum is a ligand for Toll-Like Receptor 5 and is an attractive adjuvant
because of its plasticity for generation of fusion proteins of recombinant vaccine
antigens (Hayashi et al 2001). TLRs are membrane bound receptors that recognize
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pathogen-associated molecular patterns (PAMPs) of invading microorganisms. Binding
of TLRs to PAMPs triggers a series of events that activate the immune response.

C. ANTIMICROBIAL PEPTIDES
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Between 1920 and 1950, several compounds with antimicrobial properties were
isolated from secretions of living beings, and these compounds showed biological
activity in small concentrations, with selectivity for both gram positive and negative
bacteria. (Rocha da Silva 2012).

One of these compounds was known as Lactoferrin. Lactoferrin is an iron-binding
protein found in the innate immune system of mammals biological fluids. It is known to
exert broad-spectrum antimicrobial activity against bacteria, fungi, protozoa and viruses.
Lactoferrin is known to penetrate the biofilm matrix and directly interact with cell
membranes (Ammons et al 2009). Though the mechanism of lactoferrin in biofilm
formation has yet to be fully elucidated, some research has attributed its antimicrobial
activity to its iron chelating nature. Iron ions participate in a large number of biological
processes in microorganisms and are essential in biofilm formation (Weinberg 2004).

Another group of compounds are known as cathelicidins. The cathelicidin
proteins have highly conserved N-terminal cathelin domain regions and a C-terminal
region that is less well conserved and carries antimicrobial properties. (Rocha da Silva
2012) Only one cathelicidin has been identified in humans, derived proteolytically from
the C-terminal end of the hCAP 18 protein. hCAP 18 is expressed by neutrophils and
epithelial tissues in the oral cavity and respiratory tract. hCAP18 is expressed and
cleaved by proteases to generate a 37 amino acid antimicrobial peptide known as LL-
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37. LL-37 has potent antimicrobial activity against Strep species and plays a role in
chemotaxis and stimulation of monocytes, T cells, neutrophils and mast cells.

The histatins is another group of antimicrobial cationic proteins produced by the
parotid, submandibular and sublingual glands. It exhibits apoptotic activities on
microbes and fungi. Histatin-5 is a peptide composed of 24 amino acids and inhibits C.
albicans. It binds to receptors on cell membrane and after internalization, inhibits
mitochondrial respiration by forming reactive oxygen species which damages the
mitochondrial and cytoplasmic membranes, leading to ATP efflux and cell death (Li et al
2006).

Lastly, defensins are composed of more than 380 members, and each contains
conserved motifs of 6 cysteine residues forming intramolecular disulfide bonds and beta
sheets. They are expressed in response to micro-organism induced stress and play a
role in the migration and activation of the innate immune system. (Diamond et al 2009)
There are 2 types of defensins: alpha and beta, which are structurally similar but have
distinct activities and production sites. Defensins cause cell rupture and inhibit
lipopolysaccharide production in oral streptococci (Gomes et al 2010, Schmidt et al
2011). The effect of beta-defensin 3 on 3 week old polymicrobial mature biofilm
comprising of oral bacterial species A. naeslundii, L. salivarius, Strep mutans and
E.Faecalis was tested using confocal microscopy and dead/live fluorescent staining
(Lee et al 2013) Results from the study showed that 24 hour incubation of the biofilm
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with hBD-3 (50ug/mL) resulted in a higher percentage of dead cells compared with both
untreated samples and samples treated with common disinfectant solutions.

As discussed in earlier section on biofilms, targeting specific bacteria in this
complex polymicrobial community is particularly challenging and may result in antibiotic
resistance. Conventional treatment of infectious diseases with antibiotics results in
killing of most members of the biofilm community, both pathogens and commensal
bacteria (Frias-Lopez 2015). Broad killing of bacteria allows for equal competition
between Strep mutans and nonpathogenic organisms to re-establish in the biofilm
(Sullivan et al 2011). There is an increasing need to develop a specific antimicrobial
therapy that can eliminate Strep mutans while leaving the remaining microorganisms in
the oral biome intact.

Within the past decade, antimicrobial peptides (AMPs) have been receiving
increased attention as potential therapeutic agents because they represent a novel
class of antibiotics with a wide spectrum of activity and low rate of inducing bacterial
resistance (Di Luca 2014). The number of articles on AMPs and biofilm had reached
more than 60 in 2012 and more than 70 in 2013, whereas only a few (<5) articles were
published in 2002-2003 (ISI web of science).

Antimicrobial peptides are active against a wide range of microorganisms and
metabolically inactive cells. Their main mechanism of action includes permeabilization
of the cellular membrane. This is the reason AMPs have very low bacterial resistant
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rates as compared to common antibiotics. Emergence of resistance to bilayer-disruptive
AMPs would entail changing membrane composition and organization, a “costly”
process in evolutionary terms (Zasloff 2002). Since the risk to select resistant strains in
biofilms is higher, AMPs are particularly suitable to treat biofilms because of the low rate
of induced resistance and efficacy against a wide range of microorganisms.

AMPs are attracted to the surface of microorganisms by electrostatic interactions
between anionic or cationic peptide and structures on the cell surface (Lee et al 2011).
Several modeling studies have explored the mechanism of action of these antimicrobial
peptides on cell death. After binding to the cell surface, AMPs initiate the attachment
phase. In this phase, AMPs cross through the outer lipopolysaccharide membrane in
gram-negative bacteria or the lipotechoic acid in gram positive bacteria. (Brogden 2005)
There are three different models of membrane damage created by antimicrobial
peptides. The first is the barrel-stave model where antimicrobial peptides in the
membrane form a “barrel”, allowing flow of intracellular contents out into the
extracellular environment. The second is the carpet model where AMPs accumulate
parallel to the cell surface, oriented to penetrate the lipid bilayer and form pores for the
entry of more peptides into the cell. Accumulation of peptides in the cell induces the
formation of mycelia which are released from the membrane and leads to its
disintegration. The third is the toroidal pore model where AMP helices are inserted into
the cell membrane, leading to a connection of opposing lipid monolayers to each other.
(Da Silva 2012)
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More recently, the discovery of Specifically Targeted Anti-Microbial Peptides
(STAMP) has led to a more targeted approach to control oral microbial pathogenesis. A
typical STAMP molecule consists of 2 functionally independent moieties conjoined in a
linear peptide sequent - 1) a non-specific antimicrobial peptide serving as the killing
moiety and 2) a species-specific binding peptide serving as the targeting moiety and
provides specific binding to a selected pathogen and facilitates the targeted delivery of
the antimicrobial peptide. A STAMP have been shown to be effective in eliminating
Strep mutans from a mixed-species environment without affecting closely related noncariogenic oral streptococci (Eckert et al 2006).

In a study by Eckert, a pheromone produced by Strep mutans, known as the
competence stimulating peptide (CSP) is used as the targeting domain for Strep
mutans- specific delivery of the antimicrobial. The initial CSP-derived STAMP was
constructed by synthesizing full-length Strep mutans CSP (21 amino acids) with the
antimicrobial peptide G2 (16 amino acids derived from the antimicrobial peptide
novispirin G10). This initial AMP did not reveal any antimicrobial activity possibly due to
steric hindrance. Therefore, a shorter targeting domain (16 amino acids) was created.
C16G2 consists of a Strep mutans-selective pheromone “targeting region” comprising a
fragment of CSP (C16) conjoined to a novispirin-derived “killing region” consisting of a
broad-spectrum antimicrobial peptide (G2). The C16G2 rinse was associated with
reductions in plaque and salivary Strep mutans, lactic acid production and enamel
demineralization. However, the impact on total plaque bacteria was minimal. Short
exposure of C16G2 was capable of selectively inhibiting the growth of Strep mutans
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within a multi species biofilm and in the presence of saliva for a minimum of 2 hours
without disrupting the overall health of the biofilm (Hinkle 2013). C16G2 has a rapid
mechanism of action working within less than 1 minute of exposure to bacteria. The
half-life of C16G2 however was 18.8 minutes, suggesting it is unlikely to have
meaningful effect in the oral cavity after long durations. The C16G2 rinse was also
shown to significantly elevate resting pH of dental plaque in comparison to placebo
rinse.

A study by Sullivan et al 2011 reported on the clinical efficacy of STAMP mouth
rinse. The authors reaffirmed the need to develop a specific antimicrobial therapy to
eliminate the primary cause of dental caries, Strep mutans from the oral biome without
disrupting the remaining microflora. Broad killing of the bacteria allows for equal
competition between Strep mutans and non-pathogenic organisms to re-establish
themselves in the biofilm (Sullivan 2011) While previous studies by Eckert et al 2006
has established efficacy and specificity against Strep mutans in biofilm communities and
planktonic cultures, it was unclear whether C16G2 remained active in vitro as a mouth
rinse. A 40s mouth rinse containing 0.04% C16G2 was administered once at the start of
a 4-day test phase, and no fluoride tooth paste was used. Results showed that C16G2
in 1xPBS (Phosphate Buffered Saline) reduced the viability of Strep mutans to below
10% of mock-treated controls. This suggest that C16G2 was effective against Strep
mutans at therapeutic concentrations of 25-100uM. Furthermore, in vitro hemolysis and
tissue irritation assays were performed against human cells. C16G2 had no hemolytic
activity against human RBCs at concentrations 100uM or less. Additional cytotoxicity
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test using fully differentiated buccal (EpiOral) and gingival (EpiGingival) tissues from
healthy donors were cultivated in-vitro and exposed to C16G2 (25 or 100uM). Results
showed that no ET-50 (time to reduce tissue viability to 50%) could be obtained for
STAMP-treated EpiOral and EpiGingival. To determine if the selective killing of Strep.
mutans translated into a decrease in enamel demineralization, an intra-oral caries
model was used. Enamel specimens were mounted in an upper palatal retainer and
exposed to 10% sucrose challenges 4x daily. The results showed a 3.73% increase in
enamel hardness relative to baseline in the C16G2 group, whereas a 23.0% loss of
enamel hardness in the placebo rinse group. C16G2 was also shown to significantly
elevate the resting pH of dental plaque relative to the placebo rinse (7.14 vs 6.66). This
increase in pH has 2 benefits: Firstly, a higher resting pH promotes faster
remineralization and decreases the severity of subsequent acid challenges. Secondly,
higher resting pH encourages the growth of healthy bacteria and is unfavorable for
cariogenic bacteria.

In another study by Wang et al 2015, a short synthetic amphiphilic peptide known
as 1018 was effective in inhibiting biofilm development and killing of organisms in the
biofilm. This anti-biofilm peptide binds to and stimulates the degradation of second
messenger nucleotide (p)ppGpp, involved in biofilm formation and maintenance.
10ug/ml of peptide 1018 (below MIC of >80ug/ml) had successfully inhibited plaque
biofilm formation by suppressing more than 75% of biofilm growth, compared to the
water control group. Peptide 1018 was not degraded by salivary mucins, unlike LL-37
which had a decreased antimicrobial activity due to saliva (Bucki et al 2008). The study
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also looked at the effect of peptide 1018 in combination with CHX to treat established
plaque biofilms. While the combination of 1018 and CHX did not significantly reduce
biofilm volume compared with each agent when used alone, the combined treatment led
to significant increase in the amount of dead cells within the biofilms.

There have been several issues raised in previous studies on AMPs. Although
the development of resistance to AMPs is slower than antibiotics, it is well established
that bacteria adopt a variety of efficient strategies to resist even antimicrobial peptides.
Some of the bacterial cationic antimicrobial peptides resistance mechanisms include
electrostatic repulsion of CAMPs by modification of cell envelope molecules, proteolytic
cleavage of CAMPs, production of CAMP-trapping proteins or extrusion of CAMPs by
energy-dependent efflux pumps. Others have reported resistance to antimicrobial
peptides is mainly based on the interaction with biofilm and capsule exopolymers.
These polymers work by electrostatic repulsion and/or sequestration of these
antibacterial substances (Kraus & Peschel 2006, Otto 2006). Other limitations to AMPs
include potential toxicity, susceptibility to proteases and the high cost of peptide
production. Designing the appropriate drug delivery system for AMPs is challenging
because of enzymatic degradation and unfavorable physiochemical properties such as
molecular aggregation and serum sequestration (Di Luca 2014). The high cationic
activity of most AMPs in non-physiological conditions is usually significantly reduced in
biological fluids such as plasma, serum or silver. It is also difficult to use parenterally
because of high toxicity and quick renal excretion. (da Silva 2012)
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Current strategies under investigation include chemical modification, formulation
vehicles and co-treatment with enzyme inhibitors or absorption enhancers. The use of
peptido-mimetics is a strategy to avoid proteolytic degradation and the design of short
peptides retaining antimicrobial activities is a solution to decreasing cost (Seo 2012). A
study proposed that there was a protective colonization effect of biofilm from Strep
mutans. They hypothesized that targeted elimination of Strep mutans leads to the
generation of protective biofilms with the ability to prevent secondary surface
colonization by Strep mutans (Li et al 2010). After 16 hours of inoculation of STAMPs
with spectinomycin-resistant Strep mutans derivative JM11, there was no detectable
Strep mutans cells in the sample while the untreated control contained ~10^7 Strep
mutans cells in the biofilm. The efficacy of STAMP on shorter exposure duration times
was also tested and results showed that biofilms treated for as little as five minutes
contained approximately four (STAMPE 2_1G2) and five -(STAMP C16G2) orders of
magnitude less Strep mutans cells. Furthermore, re-infection with Strep mutans was
38+/- 13 (2_1G2) to 61 +/-13 fold (C16G2) significantly less in treated biofilms
compared to untreated controls. The outcome of this study provided evidence for the
protective effect of a “normal” oral biofilm similar to the concept of “window of infection”
proposed by Caulfield et al 1993. In addition, the results suggests that whether naturally
or through STAMP treatment, established Strep mutans-free biofilm reduces the
competitive advantage of Strep mutans even in the presence of high sugar content,
preventing the shift in biofilm composition toward cariogenesis (Li et al 2010).
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D. REPLACEMENT THERAPY

Several studies on replacement therapy were published in the early twenty-first
century by the Hillman group. The basis of replacement therapy is the implantation of
relatively innocuous “effector” bacteria that can competitively exclude or outgrow
potentially disease-causing bacteria, without significantly disrupting the balance of the
existing microbial system. Hillman identified 4 properties of an effective genetically
modified effector strain for use in replacement therapy of dental caries. Firstly, it must
have a significantly reduced pathogenic potential. Secondly, it must persistently and
preemptively colonize the Strep mutans niche, preventing colonization by wild-type
strains whenever the host comes into contact with them. Thirdly, it should be able to
aggressively displace indigenous strains of Strep mutans, allowing even previously
infected subjects to be treated with replacement therapy. Lastly, it must be generally
safe and not predispose the host to other disease conditions (Hillman 2000).

They explored techniques for reducing cariogenicity in effector strains. Initially,
mutants which had defects in glucan synthesis demonstrated reduced cariogenicity in
animal models. However, they were unlikely to successfully outcompete glucansynthesizing strains for prime biofilm niches. Therefore, attention shifted toward
introducing effector strains with mutations affecting acid production. These were called
lactate dehydrogenase mutants (LDH). Lactate dehydrogenase mutants produced less
lactic acid and had reduced cariogenicity in rodents, however, this mutation was lethal
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in Strep mutans. A zygomonas mobilis gene encoding alcohol dehydrogenase was then
inserted, also known as BCS3-L1 with virtual deletion of all the LDH gene. This created
a strain that had traits of low acid production and strong mutacin production. BCS3-L1
yielded final pH values that were 0.4-1.2 pH units higher than those of its parent. The
reduced acidogenic potential is a major factor in its reduced cariogenic potential
(Hillman 2000)

BCS3-L1 was created from a clinical Strep mutans isolate. Recombinant DNA
technology was used to delete the gene encoding lactate dehydrogenase entirely and
also designed to produce elevated amounts of novel peptide antibiotic known as
mutacin 1140 (Hillman 2002), that gives it a strong selective advantage over most other
strains of Strep mutans. Mutacin production was tested in a rat model and shown to be
a phenotypic property that allows the bacteria to preemptively colonize and aggressively
displace other bacteria. This was tested in a study by Hillman et al 1998. 3 years
following a single, 3 minute infection regimen involving brushing and flossing, a
concentrated cell suspension placed onto and between the teeth resulted in all human
subjects remaining colonized by the mutant strain and producing a 3 fold elevated
amount of mutacin 1140. Reacquisition of an acidogenic phenotype by spontaneous
reversion is also extremely unlikely because of the deletion of the entire ldh gene in the
construction of BCS3-L1.

One of the greatest advantages of replacement therapy is no need for patient
compliance. However, there are several disadvantages with replacement therapy.
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Firstly, even low-virulence colonizing strain can cause infections in immunecompromised individuals. Secondly, the high intrinsic stability of the indigenous bacteria
in the biofilm can present a major obstacle in introducing a new effector strain. Success
is highly unlikely unless the effector strain is competitive (Hillman 2002). Alternatively,
the effector strain could be introduced either before establishment of the microbial
community, for instance in children immediately after the onset of tooth eruption and
before their acquisition of a wild-type strain or upon creation of an appropriate niche
following disruption of microflora by exposure to antimicrobials (Tagg 2003). Numerous
early studies have reported on the difficulty in persistently introducing laboratory strains
of Strep mutans into the mouth of humans, particularly after the indigenous microbiota
has been established. (Krasse et al 1967l Jordan et al 1972; Ruangsri et al 1977;
Svanberg et al 1981)

While creation of an innocuous effector strain has its challenges, studies have
reported on other strains of Streptococci which can competitively inhibit caries-causing
Strep mutans. A study by Becker et al in 2002 found that healthy subjects had
significantly higher number of S. sanguinis, whereas subjects with caries possessed
almost no detectable levels of S. sanguinis. High levels of S. sanguinis was correlated
with delayed acquisition of Strep mutans. (Caulfield et al 2000).

It has been documented that Strep sanguinis, Strep gordonii and Strep mutans
compete within the same niche. (Kreth et al, 2005). The success of colonization is
determined by the sequence of establishment, nutritional availability and environmental
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pressures. Strep mutans produce bacteriocins which can inhibit the growth of other
streptococci. However, Strep gordinii and Strep sanguinis are able to inhibit the growth
of Strep mutans by producing hydrogen peroxide (H2O2). Bacterocin production via the
ComDE- QS system usually occurs with an increased amount of CSP when cell density
is high. The production of H2O2 therefore, might provide an ecological advantage over
bacteriocin production during the initial colonization, when cell density is not high
enough to trigger bacteriocin production. H2O2 production is dependent on oxygen and
usually occurs during initial colonization (Marquis 1995). Oxygen tension decreases
after the biofilm reaches a certain thickness and cell density due to diffusion limitations.
Subsequently under these conditions, Strep mutans has the competitive advantage
producing bacteriocins to inhibit Strep gordonii and Strep sanguinis.

Wang and Kuramitsu (2005) reported that suppressants from Strep gordonii are
able to inhibit the production of bacteriocins, but not affect the bacteriocins directly.
They identified a protease called challisin, which is able to degrade CSP, and thus
disrupt the bacteriocin/competence regulation cascade. A search of the Strep sanguinis
genome also reveals a homolog of challisin. Another competitive inhibitor was identified
as Strep oligofermentans. Strep oligofermentans is able to utilize lactic acid produced
by cariogenic species such as Strep mutans to generate H2O2, consequently inhibiting
Strep mutans.
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E. QUORUM SENSING TARGETS

Quorum sensing (QS) is a cell density dependent communication process that
respond to the inter/intra-species signals and elicit responses to show behavioral
changes in the bacteria to aggressive forms. Bacteria communicate with each other
using hormone-like molecules known as pheromones, which increase in concentration
as a function of bacterial cell density. (Leung et al 2015)
A major mechanism of signal transduction in bacteria is the so-called twocomponent signal transduction system (TCTSs) (Li et al 2008), which enable bacteria to
regulate their gene expression and coordinate activities in response to environmental
stimuli. A typical TCTSs consists of a membrane-associated histidine kinase (HK)
protein, which senses a specific stimulus, and a cytoplasmic response regulator (RR)
protein, which enables the cells to respond to the stimulus via regulation of gene
expression (Hoch, 2000).

In Strep Mutans, the QS system known as CSP-ComDE, is achieved by
production and detection of signaling molecules in the form of a small peptide named
CSP (competence-stimulating peptide) pheromone. The CSP pheromone accumulates
not in proportion to typical cell density, but rather, to particular stresses in the oral
cavity. This suggests that the pheromone probably functions as a stress-inducible
alarmone, signaling bacteria in the biofilm to initiate an adaptive response that results in
different phenotypic outcomes (Leung et al 2015). The CSP pheromone, once reaching
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its threshold concentration, directly interacts with the membrane-bound histidine kinase
receptor, ComD, to orchestrate a signaling response. The interaction of CSP
pheromone with ComD triggers the dimerization and autophosphorylation of the
receptor, and initiates the phosphorylation and subsequent activation of cytoplasmic
response regulator ComE. Activated ComE directly activates the expression of several
genes encoding bacteriocins and bacteriocin-like peptides and indirectly regulates SigX,
involved in the control of the competence regulon.

Interference with the QS signaling is a promising avenue toward development of
novel therapeutics. QS peptides could be useful for inducing targeting suicide.
Alternatively, diminishing QS mechanisms could be considered to prevent persistence
and genetic heterogeneity through the spreading of potential antibiotic resistance
genes. (Leung 2015) The ability to interfere with bacterial QS could manipulate the
composition of pathogenic biofilms. Once the threshold concentration is reached
(“quorum” or the number of bacteria required to activate the QS system), the QS
molecule initiates a signaling cascade culminating in a population-wide differential
regulation of target genes enabling bacteria to act as multicellular organisms. The CSPdependent QS system in Strep mutans has been found to regulate physiological
activities including bacteriocin production, competence development, biofilm formation
and stress response.
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Bacterial programmed cell death is a kind of altruistic act that provides a way for
species to survive stresses at the expense of some of its cells. Death by suicide of a
subpopulation may leave more resources for the surviving population and thereby
improve long-term survival of the species. Previous studies have shown that CSPinduced PCD was involved in the release of extracellular DNA in the biofilm,
“contributing to the architecture of the biofilm matrix and providing a mechanism for
dissemination of fitness-enhancing genes under stress” (Leung 2015). In a study by
Zhang et al 2009, late-stage biofilm formation by Strep mutans was significantly
increased in the presence of exogenous CSP. The addition of synthetic CSP correlated
with cell death, release of genomic DNA, induced competence for DNA uptake and
increased biofilm formation. Cell death benefits the attachment of surviving cells and
induces subsequent biofilm differentiation and dispersal. (Bayles et al 2007, Petersen et
al 2005)

Some bacteria enter a state of normalcy. These non-growing dormant cells
known as persisters, are tolerant to all antibiotics currently in use without expressing a
drug resistance mechanism (Leung 2015). Persisters are phenotypic variants of the
wild-type strain that arise in a clonal population of genetically identical cells. Since
persisters are in a growth-arrested physiological state, antibiotics that target essential
cellular processes are ineffective in killing these cells. The formation of persisters has
been described as “spontaneous” (Cohen 2013) and the existence of a small
subpopulation of persisters in any growing bacterial population reflects a populationlevel strategy of survival in a rapidly changing environment. QS-deficient mutants did
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not demonstrate the ability to produce persister phenotypes which suggests that the
CSP-ComDE QS system may be a deterministic mechanism for persister formation
(Leung 2012). Recently, it was shown that an intact signal relay between ComDE, Com
RS to the activation of SigX was required for the stress-induced persistence phenotype
(Leung et al, 2015). These results showed the importance of the QS system in mounting
an adaptive stress response within a subpopulation of S.mutans to form dormant
persisters for survival of the species.

Among the therapeutic targets in QS system are CSP. STAMPs (selectively
targeted antimicrobial peptides) were designed to have a targeted domain (8-amino acid
region of the CSP) fused to an antimicrobial peptide domain and shows a robust
species-specific activity that eliminates S.mutans without affecting the other noncariogenic streptococci. It was reported that C-terminal truncated CSP peptides could
competitively affect the QS activity and structural motif in the C-terminal domain
restoring the activation of the QS signal transduction pathway (Syvitski 2007). Another
therapeutic target is the autoinducer-2 (AI-2). AI-2 is a furanosyl borate diester, known
to mediate interspecies communication. AI-2 is encoded by the highly conserved luxS
gene, and mutation in the luxS gene of Strep mutans leads to an altered biofilm
structure and also decreases the production of bacteriocin and mutacin I (Yoshida et al
2005, Merritt et al 2003). A study showed that synthetic furanone (Z)-5bromomethylene-2(5H)-furanone, a potential inhibitor of AI-2, was able to reduce biofilm
formation in Strep anginosus, Strep intermedius and Strep mutans wild type strains,
both when coated on a surface or when added to medium. (Lonn-Stensrud et al 2007)
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The effect was more pronounced on furanone-coated surfaces, where the reduction
was 76% and 63% in Strep intermedius and Strep mutans respectively. The reduced
biofilm formation in all 3 streptococci studied demonstrated that the effect of furanone
was not species specific. Furthermore, the furanone concentrations used had no effect
on total growth of bacteria and therefore, reduces the risk of antimicrobial resistance
development. Another therapeutic target is the ABC transporter (ComA), which play a
vital role in the maturation and secretion of CSP (Kotake et al 2008). More specifically,
the PEP domains of ComA would be an ideal target for the development of drugs to
inhibit biofilm formation. Mutations at the active site of PEP has resulted in the complete
loss of the catalytic activity of PEP domain. Based on the observation and substrate
specificity of peptidase domain of ComA, Kaur et al 2015 hypothesized that the
therapeutic inhibition of the PEP domain of ComA will halt the maturation and secretion
of CSP from Strep mutans.

Another QS system known as HK/RR 11 is involved in Strep mutans survival at
acidic pH. (Li et al 2008). Simultaneous inactivation of the ComCDE quorum-sensing
system and HK/RR11 two-component regulatory system resulted in additive attenuation
of the virulence and cariogenic potential of Strep mutans, since inactivation of either of
these systems alone did not result in effects of the same degree or extent. This
suggests that the ComCDE and HK/RR11 signal transduction systems function
independently to regulate physiological activities, ecological fitness and virulence of
Strep mutans (Li et al 2008). An interesting finding of this study was that inactivation of
the ComCDE QS system alone did not affect oral colonization and succession of Strep
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mutans in rats, however the caries score was significantly lower than that of the parental
strain, indicating that colonization of Strep mutans in dental biofilms may not be
sufficient to explain its virulence and cariogenic activity, although it is a pre-requisite for
infection (Li et al 2008). The ComCDE system also controls production of several
bacteriocin and bacteriocin immunity proteins. These compounds can kill other related
species in favor of Strep mutans in the biofilm, and the release of DNA can be used by
Strep mutans for genetic exchange (Kreth et al 2005)

Several recent studies have described the strategy and application of quorumsensing antagonists to prevent opportunistic infections caused by P. aeruginosa and S.
aureus (Hentzer et al 2003). The major advantage in using anti-quorum-sensing
compounds is that it specifically blocks or overrides bacterial signaling pathways that
confer pathogenicity without significant effects on bacterial viability as a whole. When
bacterial viability is not disturbed, there is much less selection pressure to create
resistant microbes (Li et al 2008).
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F. NANOPARTICLES

Nanoparticles are classified as particles with a size no greater than 100nm. Silver
and copper have received the most attention in dentistry. An inverse relationship
between the size of nanoparticles and antimicrobial activity has been demonstrated. a
range of 1-10nm have been shown to have the greatest killing activity against bacteria
compared with larger particles (Morones et al 2005) Bacteria are less likely to acquire
resistance to metal nanoparticles compared to conventional broad-spectrum antibiotics
because metals act on a broad range of microbial targets and many mutations would
have to occur in order for micro-organisms to resist their antimicrobial activity (Allaker et
al 2014) Metal oxides which produce a reactive oxygen species when exposed to UV
light such as titanium dioxide (TiO2) and since oxide (ZnO) are increasingly used in
antimicrobial applications (Allaker et al 2014)

A pertinent issue in restorative and preventative dentistry today involves the
development of secondary caries. Traditional composites in vivo have been shown to
accumulate more biofilms than other restorative materials. Plaque formation adjacent to
restoration margins could result in secondary caries. More than half of all restorations
fail within 10 years and 50-70% of all restorations placed are replacements of failed
restorations (Cheng et al 2015). There has been a surge in focus on restorative
materials which can minimize the risk of secondary caries. A study by Cheng et al 2015
investigated the incorporation of nanoparticles of silver (NAg) into
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composites/adhesives and quaternary ammonium methacrylates (QAMs) to combat
biofilms. Nanoparticles of amorphous calcium phosphate (NACP) showed release of
calcium/phosphate ions which remineralized tooth lesions and neutralized acids. The
combination of NAg, QAM and NACP lead to the formation of a new class of
composites and adhesives which is not only effective against bacteria but also promotes
remineralization.

Silver has been extensively investigated for antimicrobial activity and is also
relatively less toxic to human cells at very low concentrations. Silver has antibacterial,
antifungal and antiviral properties. Though mechanism of action of Ag+ is not
completely understood, studies have shown that the positive charge on Ag+ creates an
electrostatic attraction between the negative charge of the bacterial cell membrane.
Proteins in membrane or phosphorous containing elements such as DNA may be
preferential binding sites for silver nanoparticles (Kim et al 2007) Nano Ag (Nag) has a
high surface-area-to-mass ratio, hence a small amount of NAg was sufficient for the
composite to be strongly antibacterial. Furthermore, a small amount of NAg did not
compromise the color, esthetics or mechanical properties of the composite. (Cheng et al
2015) Silver ions have the following 3 main antibacterial effects: destruction of cell wall
structure; denaturation of cytoplasmic enzyme and inhibition of microbic DNA replication
(Peng et al 2012).

In a study by Cheng et al. 2012, nano composites were developed containing
amorphous calcium phosphate (ACP) or calcium fluoride (CaF2) nanoparticles and CHX
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particles. Four nano composites were created with fillers: nano ACP, nano ACP + 10%
CHX, nano CaF2, nano CaF2 + 10% CHX. Results showed that the release of CHX
from the ACP nano composite was similar to that of the CaF2 nanocomposite. After 3
days, the NanoCaF2 + CHX and NanoACP + CHX had pH levels that remained at 6.5
or higher. For NaCaF2 alone, the pH dropped to 4.6, while NanoACP alone fell to a pH
of 4.2. Furthermore, nano composites with CHX decreased CFU Strep. mutan counts by
1000 fold compared to regular non-releasing composite. This study demonstrated that
restorations that release CHX have the potential of eliminating bacteria in the vicinity.
Consequently, this helps promote recolonization of the area with non-acidogenic
bacteria and prevent recurrent caries. NanoCaF2 + CHX had a biofilm pH comparable
to NanoACP + CHX, and the author proposed that this is likely due to the F ion release
of CaF2. The F ion can help reduce acid production of bacteria, via inhibition of
metabolic pathways. In addition to the anti-cariogenic activity of these nanoparticle
materials, the flexural strength also remains comparable with commercial composites
without fluoride.

Metal oxide nanoparticles have also been studied for its antimicrobial
properties. The common oxides are those of copper, zinc, titanium and tungsten. Since
metals target a broad range of microbial targets, development of resistance against
metal oxide nanoparticles is highly unlikely (Allaker et al 2014). Zinc oxide has been
shown to have a high degree of selective toxicity to bacteria and good biocompatibility.
In a study by Eshed et al 2012, sonochemical coating of artificial teeth with ZnO and
CuO nanoparticles significantly inhibited biofilm formation of Strep mutans. In another
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study investigating the antibacterial properties of incoporating silver and zinc oxide
nanoparticles in composite resins (Kasraei et al 2014), results showed that composite
resins containing silver or zinc-oxide had a higher antibacterial activity against Strep
mutans and Lactobacillus. Ramazanzadeh et al 2015 published findings on a study
comparing the antibacterial effects of ZnO and CuO nanoparticles coated brackets on
Strep mutans. The study found that CuO and ZnO-CuO nanoparticles coated brackets
have better antimicrobial effect on Strep mutans than ZnO coated brackets. In fact, no
colony growth was seen after 2 hours in both CuO and CuO-ZnO coated brackets. The
growth of Strep mutans was significantly reduced by ZnO nanoparticles after 6-24
hours.
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VIII. NATURAL PRODUCTS

Natural products have been shown to inhibit bacterial growth, acid production
and acidurance, exopolysaccharide synthesis and bacterial adherence. These products
are usually associated with secondary metabolites produced by an organism, and there
are 3 main groups: 1) phenolic compounds containing benzene rings, hydrogen and
oxygen 2) alkaloids - nitrogen-containing compounds and 3) terpenoids - made from
mevalonic acid and composed almost entirely of carbon and hydrogen.
Among the inhibitors of bacterial growth, Camellia sinensis has been shown to
contain specific catechins from green tea which have antibacterial activity against S.
mutants and S. sobrinus. The antibacterial inhibitory effect seems to be related to the
“presence of three hydroxy moieties at 3’, 4’ and 5’ on the B ring of the catechin and
epicatechin molecular structure”. (Sakanaka et al 1989). Essential oils affect the
bacterial viability by compromising the integrity of the bacterial membrane. Terpenoids
is the main chemical group. Thymol and eugenol inhibit a wide range of oral
microorganisms including Strep mutans (Shapiro et al 1994). The antibacterial activity of
tt-farnesol, oleic and linoleic acids may be related to their lipophilic characteristics and
increase proton permeability.
Inhibitors of acid production and acidurance include 7-epiclusianone, tt-farnesol
and some cranberry flavonoids. These have been reported to increase the proton
permeability of Strep mutans cells, causing cytoplasmic acidification and inhibiting the
acid-sensitive intracellular glycolytic enzymes (Koo et al 2010). Psidium chatelaine and
epigallocatechin gullet have been shown to disrupt the expression and activity of

51

specific enzymes involved in the glycolytic pathway of Strep mutans, including lactate
dehydrogenase. (Hirasawa et al 2006, Brighenti et al 2008)
Polyphenolic compounds have been extensively studied in their ability to reduce
gluten synthesis and exopolysaccharide synthesis. Various polyphenols from the leaves
of C.Sinensis (extracts of green or oolong tea), propolis, cacao bean husk, cranberry
and often traditional plants (Serindeia warnecki, Azadirachta indica, R.gardneriana and
M. chances) exhibit inhibitory effects against gluten synthesis (Jeon et al 2011). Most of
the effective compounds in natural products have been found in polyphenolic
compounds (Cheng et al 2015).
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IX. CONCLUSION

Dental caries remains an infectious disease and a public health burden
worldwide. Almost 95% of the world population is affected by caries at different ages.
While usually not life-threatening, the development of cavities is inversely related to
quality of life and overall health. (Sullivan 2011) With the introduction of refined sugar
into the modern diet and an improved understanding of the pathogenesis of dental
caries, the need for novel approaches to caries prevention has become is a key
undertaking for addressing the caries burden in the 21st century.
Currently, the most effective measures against caries development is the use of
fluoride-containing products, such as varnishes, toothpastes and silver diamine
products. Individual behaviors with regard to oral hygiene and diet is also key in the
balance between cariogenic and non-cariogenic plaque. (Sullivan et al 2011) The widespectrum antibiotic use combined with emergence of drug resistant strains highlight the
fundamental need for new “targeted” antibiotic therapies to combat specific mucosal
pathogens with minimal impact on the remaining oral microflora (Eckert et al 2012).
Furthermore, broad killing of bacteria results in equal competition between Strep
mutans and nonpathogenic organisms in the re-establishment of the biofilm.
While fluoride is able to reduce the incidence and prevalence of dental caries and
should remain an important component of oral health regimen, it has limited efficacy in
killing cariogenic bacteria residing in dental plaque (Hamilton 1990). This could explain
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the persistence of dental caries within populations, despite fluoride’s well documented
clinical efficacy (Milgrom et al 2009, Anderson and Shi 2006).
Vaccines including both animate (attenuated bacterial factors) and inanimate
(liposomes, microparticles) delivery systems have been shown to provide efficient
targeting of Streptococcus mutans. Both passive and active immunization approaches
in animal models and human clinical trials have shown success in delaying the
recolonization of Strep mutans. (Russell et al 1999, Ma et al 1990)
Antimicrobial peptides have been receiving increased attention as potential
therapeutic agents within the past decade because they represent a novel class of
antibiotics with a wide spectrum of activity and low rate of inducing bacterial resistance.
Specifically Targeted Antimicrobial Peptides (STAMPs) have been developed
comprising of a species-specific targeting region, linker region and a wide-spectrum
killing domain. STAMP treatment has received approval by the Food and Drug
Administration to be studied as an Investigational New Drug and is currently in Phase II
clinical trials for safety and efficacy. (Eckert et al 2006, 2012, Kaplan et al 2011)
Replacement therapy involves the implantation of relatively innocuous “effector”
bacteria that can competitively exclude or outgrow potentially disease-causing bacteria,
without significantly disrupting the balance of the existing microbial system. Many early
studies however, have reported on the challenge in successfully introducing effector
strains into the mouth of humans. (Hillman et al 2000, 2002, Tagg et al 2003)
Quorum sensing is the secretion and detection of a diffusible molecule by the
community members can lead microbial species to suddenly change their behavior.
Interference with the QS signaling is a promising avenue toward development of novel
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therapeutics. QS peptides could be useful for inducing bacterial programmed cell death.
The ability to interfere with bacterial QS could manipulate the composition of pathogenic
biofilms. (Leung et al 2015)
Nanoparticles have become increasingly studied in its use in composite dental
materials. This approach was developed with the goal of reducing the incidence of
secondary caries. It has been reported that bacteria are less likely to acquire resistance
to metal nanoparticles compared to conventional broad-spectrum antibiotics because
metals act on a broad range of microbial targets and many mutations would have to
occur in order for micro-organisms to resist their antimicrobial activity. (Allaker et al
2014)
Lastly, natural products have been shown in in vitro experiments to inhibit
bacterial growth, acid production and acidurance, exopolysaccharide synthesis and
bacterial adherence. (Jeon JG 2011) The 3 main groups of natural products include
phenolic compounds, alkaloids and terpenoids, of which phenolic compounds have
been proven most effective. However, the specific mechanisms of anticaries effects are
still unclear for most natural products. (Cheng et al 2015)
While these treatment modalities have been shown to target different virulence
factors of Strep mutans, there is not one approach that has consistently shown a safe
and efficacious approach against caries in humans. With the goal in mind to address the
large caries burden worldwide, the next step would be to develop a new drug that could
predictably and selectively target Strep mutans while being readily accessible to all
populations regardless of socioeconomic status.

55

X. BIBLIOGRAPHY

1. Aas JA, Paster BJ, Stokes LN, Olsen I, Dewhirst FE. Defining the normal bacterial
flora of the oral cavity. J Clin Microbiol. 2005 Nov;43(11):5721-32.
2. Abiko Y. Passive immunization against dental caries and periodontal disease:
development of recombinant and human monoclonal antibodies. Crit Rev Oral Biol Med.
2000;11(2):140-58.
3. Ahovuo-Saloranta A, Forss H, Walsh T, Hiiri A, Nordblad A, Makela M, et al. Sealants
for preventing dental decay in the permanent teeth. Cochrane Database Syst Rev. 2013
Mar 28;3:CD001830.
4. Allaker RP. The use of nanoparticles to control oral biofilm formation. J Dent Res.
2010 Nov;89(11):1175-86.
5. Allaker RP, Douglas CW. Novel anti-microbial therapies for dental plaque-related
diseases. Int J Antimicrob Agents. 2009 Jan;33(1):8-13.
6. Allaker RP, Ian Douglas CW. Non-conventional therapeutics for oral infections.
Virulence. 2015;6(3):196-207.
7. Allaker RP, Memarzadeh K. Nanoparticles and the control of oral infections. Int J
Antimicrob Agents. 2014 Feb;43(2):95-104.
8. Ammons MC, Ward LS, Fisher ST, Wolcott RD, James GA. In vitro susceptibility of
established biofilms composed of a clinical wound isolate of Pseudomonas aeruginosa
treated with lactoferrin and xylitol. Int J Antimicrob Agents. 2009 Mar;33(3):230-6.
9. Anderson MH, Shi W. A probiotic approach to caries management. Pediatr Dent.
2006 Mar-Apr;28(2):151,3; discussion 192-8.

56

10. Aoki W, Kuroda K, Ueda M. Next generation of antimicrobial peptides as molecular
targeted medicines. J Biosci Bioeng. 2012 Oct;114(4):365-70.
11. Balakrishnan M, Simmonds RS, Tagg JR. Dental caries is a preventable infectious
disease. Aust Dent J. 2000 Dec;45(4):235-45.
12. Baltzer SA, Brown MH. Antimicrobial peptides: promising alternatives to
conventional antibiotics. J Mol Microbiol Biotechnol. 2011;20(4):228-35.
13. Banting DW, Papas A, Clark DC, Proskin HM, Schultz M, Perry R. The effectiveness
of 10% chlorhexidine varnish treatment on dental caries incidence in adults with dry
mouth. Gerodontology. 2000 Dec;17(2):67-76.
14. Batoni G, Maisetta G, Esin S. Antimicrobial peptides and their interaction with
biofilms of medically relevant bacteria. Biochim Biophys Acta. 2015 Oct 23.
15. Bayles KW. The biological role of death and lysis in biofilm development. Nat Rev
Microbiol. 2007 Sep;5(9):721-6.
16. Becker MR, Paster BJ, Leys EJ, Moeschberger ML, Kenyon SG, Galvin JL, et al.
Molecular analysis of bacterial species associated with childhood caries. J Clin
Microbiol. 2002 Mar;40(3):1001-9.
17. Besinis A, De Peralta T, Tredwin CJ, Handy RD. Review of nanomaterials in
dentistry: interactions with the oral microenvironment, clinical applications, hazards, and
benefits. ACS Nano. 2015 Mar 24;9(3):2255-89.
18. Borzabadi-Farahani A, Borzabadi E, Lynch E. Nanoparticles in orthodontics, a
review of antimicrobial and anti-caries applications. Acta Odontol Scand. 2014
Aug;72(6):413-7.
19. Bowen WH. The Stephan Curve revisited. Odontology. 2013 Jan;101(1):2-8.

57

20. Brandtzaeg P. Induction of secretory immunity and memory at mucosal surfaces.
Vaccine. 2007 Jul 26;25(30):5467-84.
21. Brighenti FL, Luppens SB, Delbem AC, Deng DM, Hoogenkamp MA, Gaetti-Jardim
E,Jr, et al. Effect of Psidium cattleianum leaf extract on Streptococcus mutans viability,
protein expression and acid production. Caries Res. 2008;42(2):148-54.
22. Brogden KA. Antimicrobial peptides: pore formers or metabolic inhibitors in
bacteria? Nat Rev Microbiol. 2005 Mar;3(3):238-50.
23. Bucki R, Namiot DB, Namiot Z, Savage PB, Janmey PA. Salivary mucins inhibit
antibacterial activity of the cathelicidin-derived LL-37 peptide but not the cationic steroid
CSA-13. J Antimicrob Chemother. 2008 Aug;62(2):329-35.
24. Caldwell RC, Sandham HJ, Mann WV,Jr, Finn SB, Formicola AJ. 1. The effect of a
dextranase mouthwash on dental plaque in young adults and children. J Am Dent
Assoc. 1971 Jan;82(1):124-31.
25. Carlsson J. A numerical taxonomic study of human oral streptococci. Odontol Revy.
1968;19(2):137-60.
26. Caufield PW, Cutter GR, Dasanayake AP. Initial acquisition of mutans streptococci
by infants: evidence for a discrete window of infectivity. J Dent Res. 1993 Jan;72(1):3745.
27. Caufield PW, Dasanayake AP, Li Y, Pan Y, Hsu J, Hardin JM. Natural history of
Streptococcus sanguinis in the oral cavity of infants: evidence for a discrete window of
infectivity. Infect Immun. 2000 Jul;68(7):4018-23.

58

28. Chen L, Ren Z, Zhou X, Zeng J, Zou J, Li Y. Inhibition of Streptococcus mutans
biofilm formation, extracellular polysaccharide production, and virulence by an oxazole
derivative. Appl Microbiol Biotechnol. 2016 Jan;100(2):857-67.
29. Cheng L, Weir MD, Zhang K, Xu SM, Chen Q, Zhou X, et al. Antibacterial
nanocomposite with calcium phosphate and quaternary ammonium. J Dent Res. 2012
May;91(5):460-6.
30. Cheng L, Zhang K, Weir MD, Melo MA, Zhou X, Xu HH. Nanotechnology strategies
for antibacterial and remineralizing composites and adhesives to tackle dental caries.
Nanomedicine (Lond). 2015 Mar;10(4):627-41.
31. Childers NK, Zhang SS, Michalek SM. Oral immunization of humans with
dehydrated liposomes containing Streptococcus mutans glucosyltransferase induces
salivary immunoglobulin A2 antibody responses. Oral Microbiol Immunol. 1994
Jun;9(3):146-53.
32. Chu CH, Mei L, Seneviratne CJ, Lo EC. Effects of silver diamine fluoride on dentine
carious lesions induced by Streptococcus mutans and Actinomyces naeslundii biofilms.
Int J Paediatr Dent. 2012 Jan;22(1):2-10.
33. Clarke J. On the bacterial factor in the etiology of dental caries. Institute of
Pathology and Research, St Mary's Hospital, London. 1924.
34. Clarkson J. International collaborative research on fluoride. J Dent Res.
2000;79:893-904.
35. Cohen NR, Lobritz MA, Collins JJ. Microbial persistence and the road to drug
resistance. Cell Host Microbe. 2013 Jun 12;13(6):632-42.

59

36. da Silva BR, de Freitas VA, Carneiro VA, Arruda FV, Lorenzon EN, de Aguiar AS, et
al. Antimicrobial activity of the synthetic peptide Lys-a1 against oral streptococci.
Peptides. 2013 Apr;42:78-83.
37. da Silva BR, de Freitas VA, Nascimento-Neto LG, Carneiro VA, Arruda FV, de
Aguiar AS, et al. Antimicrobial peptide control of pathogenic microorganisms of the oral
cavity: a review of the literature. Peptides. 2012 Aug;36(2):315-21.
38. Dehghani M, Abtahi M, Sadeghian H, Shafaee H, Tanbakuchi B. Combined
chlorhexidine-sodiumfluoride mouthrinse for orthodontic patients: Clinical and
microbiological study. J Clin Exp Dent. 2015 Dec 1;7(5):e569-75.
39. Demuth DR, Lammey MS, Huck M, Lally ET, Malamud D. Comparison of
Streptococcus mutans and Streptococcus sanguis receptors for human salivary
agglutinin. Microb Pathog. 1990 Sep;9(3):199-211.
40. Di Luca M, Maccari G, Nifosi R. Treatment of microbial biofilms in the post-antibiotic
era: prophylactic and therapeutic use of antimicrobial peptides and their design by
bioinformatics tools. Pathog Dis. 2014 Apr;70(3):257-70.
41. Diamond G, Beckloff N, Weinberg A, Kisich KO. The roles of antimicrobial peptides
in innate host defense. Curr Pharm Des. 2009;15(21):2377-92.
42. Ding Y, Wang W, Fan M, Tong Z, Kuang R, Jiang W, et al. Antimicrobial and antibiofilm effect of Bac8c on major bacteria associated with dental caries and
Streptococcus mutans biofilms. Peptides. 2014 Feb;52:61-7.
43. Dong L, Tong Z, Linghu D, Lin Y, Tao R, Liu J, et al. Effects of sub-minimum
inhibitory concentrations of antimicrobial agents on Streptococcus mutans biofilm
formation. Int J Antimicrob Agents. 2012 May;39(5):390-5.

60

44. Duchin S, van Houte J. Relationship of Streptococcus mutans and lactobacilli to
incipient smooth surface dental caries in man. Arch Oral Biol. 1978;23(9):779-86.
45. Eckert R, He J, Yarbrough DK, Qi F, Anderson MH, Shi W. Targeted killing of
Streptococcus mutans by a pheromone-guided "smart" antimicrobial peptide. Antimicrob
Agents Chemother. 2006 Nov;50(11):3651-7.
46. Eckert R, Sullivan R, Shi W. Targeted antimicrobial treatment to re-establish a
healthy microbial flora for long-term protection. Adv Dent Res. 2012 Sep;24(2):94-7.
47. Eshed M, Lellouche J, Matalon S, Gedanken A, Banin E. Sonochemical coatings of
ZnO and CuO nanoparticles inhibit Streptococcus mutans biofilm formation on teeth
model. Langmuir. 2012 Aug 21;28(33):12288-95.
48. Falsetta ML, Klein MI, Lemos JA, Silva BB, Agidi S, Scott-Anne KK, et al. Novel
antibiofilm chemotherapy targets exopolysaccharide synthesis and stress tolerance in
Streptococcus mutans to modulate virulence expression in vivo. Antimicrob Agents
Chemother. 2012 Dec;56(12):6201-11.
49. Filler SJ, Gregory RL, Michalek SM, Katz J, McGhee JR. Effect of immune bovine
milk on Streptococcus mutans in human dental plaque. Arch Oral Biol. 1991;36(1):41-7.
50. Fitzgerald RJ, Keyes PH. Demonstration of the etiologic role of streptococci in
experimental caries in the hamster. J Am Dent Assoc. 1960 Jul;61:9-19.
51. Fjell CD, Hiss JA, Hancock RE, Schneider G. Designing antimicrobial peptides: form
follows function. Nat Rev Drug Discov. 2011 Dec 16;11(1):37-51.
52. Frias-Lopez J. Targeting specific bacteria in the oral microbiome. Trends Microbiol.
2015 Sep;23(9):527-8.
53. Gibbons RJ, van Houte J. Dental caries. Annu Rev Med. 1975;26:121-36.

61

54. Gomes Pde S, Fernandes MH. Defensins in the oral cavity: distribution and
biological role. J Oral Pathol Med. 2010 Jan;39(1):1-9.
55. Greer M. Hawaii public school oral health assessmen. Honolulu: Hawaii Department
of Health, Division of Dental Health. 1999.
56. Guggenheim B. Streptococci of dental plaques. Caries Res. 1968;2(2):147-63.
57. Guo L, McLean JS, Yang Y, Eckert R, Kaplan CW, Kyme P, et al. Precision-guided
antimicrobial peptide as a targeted modulator of human microbial ecology. Proc Natl
Acad Sci U S A. 2015 Jun 16;112(24):7569-74.
58. Hajishengallis G, Darveau RP, Curtis MA. The keystone-pathogen hypothesis. Nat
Rev Microbiol. 2012 Oct;10(10):717-25.
59. Hajishengallis G, Michalek SM. Current status of a mucosal vaccine against dental
caries. Oral Microbiol Immunol. 1999 Feb;14(1):1-20.
60. Hajishengallis G, Nikolova E, Russell MW. Inhibition of Streptococcus mutans
adherence to saliva-coated hydroxyapatite by human secretory immunoglobulin A (SIgA) antibodies to cell surface protein antigen I/II: reversal by IgA1 protease cleavage.
Infect Immun. 1992 Dec;60(12):5057-64.
61. Hamada S, Horikoshi T, Minami T, Kawabata S, Hiraoka J, Fujiwara T, et al. Oral
passive immunization against dental caries in rats by use of hen egg yolk antibodies
specific for cell-associated glucosyltransferase of Streptococcus mutans. Infect Immun.
1991 Nov;59(11):4161-7.
62. Hamada S, Slade HD. Biology, immunology, and cariogenicity of Streptococcus
mutans. Microbiol Rev. 1980 Jun;44(2):331-84.

62

63. Hamilton IR. Biochemical effects of fluoride on oral bacteria. J Dent Res. 1990
Feb;69 Spec No:660,7; discussion 682-3.
64. Hannig M, Hannig C. Nanotechnology and its role in caries therapy. Adv Dent Res.
2012 Sep;24(2):53-7.
65. Hatta H, Tsuda K, Ozeki M, Kim M, Yamamoto T, Otake S, et al. Passive
immunization against dental plaque formation in humans: effect of a mouth rinse
containing egg yolk antibodies (IgY) specific to Streptococcus mutans. Caries Res.
1997;31(4):268-74.
66. Hayashi F, Smith KD, Ozinsky A, Hawn TR, Yi EC, Goodlett DR, et al. The innate
immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature. 2001
Apr 26;410(6832):1099-103.
67. He J, Eckert R, Pharm T, Simanian MD, Hu C, Yarbrough DK, et al. Novel synthetic
antimicrobial peptides against Streptococcus mutans. Antimicrob Agents Chemother.
2007 Apr;51(4):1351-8.
68. Hentzer M, Givskov M. Pharmacological inhibition of quorum sensing for the
treatment of chronic bacterial infections. J Clin Invest. 2003 Nov;112(9):1300-7.
69. Hillman JD. Genetically modified Streptococcus mutans for the prevention of dental
caries. Antonie Van Leeuwenhoek. 2002 Aug;82(1-4):361-6.
70. Hillman JD, Brooks TA, Michalek SM, Harmon CC, Snoep JL, van Der Weijden CC.
Construction and characterization of an effector strain of Streptococcus mutans for
replacement therapy of dental caries. Infect Immun. 2000 Feb;68(2):543-9.
71. Hinkle R. S.T.A.M.P. of Approval: The Use of Specifically Targeted Antimicrobial
Peptides in the Reduction of Dental Caries. . 2015;27(1):10.

63

72. Hirasawa M, Takada K, Otake S. Inhibition of acid production in dental plaque
bacteria by green tea catechins. Caries Res. 2006;40(3):265-70.
73. Hoch JA. Two-component and phosphorelay signal transduction. Curr Opin
Microbiol. 2000 Apr;3(2):165-70.
74. Hoiby N, Bjarnsholt T, Givskov M, Molin S, Ciofu O. Antibiotic resistance of bacterial
biofilms. Int J Antimicrob Agents. 2010 Apr;35(4):322-32.
75. Horev B, Klein MI, Hwang G, Li Y, Kim D, Koo H, et al. pH-activated nanoparticles
for controlled topical delivery of farnesol to disrupt oral biofilm virulence. ACS Nano.
2015 Mar 24;9(3):2390-404.
76. Jeon JG, Rosalen PL, Falsetta ML, Koo H. Natural products in caries research:
current (limited) knowledge, challenges and future perspective. Caries Res.
2011;45(3):243-63.
77. Jordan HV, Englander HR, Engler WO, Kulczyk S. Observations on the implantation
and transmission of Streptococcus mutans in humans. J Dent Res. 1972 MarApr;51(2):515-8.
78. Jorge P, Lourenco A, Pereira MO. New trends in peptide-based anti-biofilm
strategies: a review of recent achievements and bioinformatic approaches. Biofouling.
2012;28(10):1033-61.
79. Kanapka JA, Kleinberg I. Catabolism of arginine by the mixed bacteria in human
salivary sediment under conditions of low and high glucose concentration. Arch Oral
Biol. 1983;28(11):1007-15.
80. Kasraei S, Sami L, Hendi S, Alikhani MY, Rezaei-Soufi L, Khamverdi Z.
Antibacterial properties of composite resins incorporating silver and zinc oxide

64

nanoparticles on Streptococcus mutans and Lactobacillus. Restor Dent Endod. 2014
May;39(2):109-14.
81. Kaste LM, Selwitz RH, Oldakowski RJ, Brunelle JA, Winn DM, Brown LJ. Coronal
caries in the primary and permanent dentition of children and adolescents 1-17 years of
age: United States, 1988-1991. J Dent Res. 1996 Feb;75 Spec No:631-41.
82. Kaur G, Rajesh S, Princy SA. Plausible Drug Targets in the Streptococcus mutans
Quorum Sensing Pathways to Combat Dental Biofilms and Associated Risks. Indian J
Microbiol. 2015 Dec;55(4):349-56.
83. Keijser BJ, Zaura E, Huse SM, van der Vossen JM, Schuren FH, Montijn RC, et al.
Pyrosequencing analysis of the oral microflora of healthy adults. J Dent Res. 2008
Nov;87(11):1016-20.
84. KEYES PH. The infectious and transmissible nature of experimental dental caries.
Findings and implications. Arch Oral Biol. 1960 Mar;1:304-20.
85. Keyes PH, Hicks MA, Goldman M, McCabe RM, Fitzgerald RJ. 3. Dispersion of
dextranous bacterial plaques on human teeth with dextranase. J Am Dent Assoc. 1971
Jan;82(1):136-41.
86. Kilian M, Thylstrup A, Fejerskov O. Predominant plaque flora of Tanzanian children
exposed to high and low water fluoride concentrations. Caries Res. 1979;13(6):330-43.
87. Kim JS, Kuk E, Yu KN, Kim JH, Park SJ, Lee HJ, et al. Antimicrobial effects of silver
nanoparticles. Nanomedicine. 2007 Mar;3(1):95-101.
88. Kim MA, Lee MJ, Jeong HK, Song HJ, Jeon HJ, Lee KY, et al. A monoclonal
antibody specific to glucosyltransferase B of Streptococcus mutans GS-5 and its
glucosyltransferase inhibitory efficiency. Hybridoma (Larchmt). 2012 Dec;31(6):430-5.

65

89. Kleinberg I. A mixed-bacteria ecological approach to understanding the role of the
oral bacteria in dental caries causation: an alternative to Streptococcus mutans and the
specific-plaque hypothesis. Crit Rev Oral Biol Med. 2002;13(2):108-25.
90. Koga T, Oho T, Shimazaki Y, Nakano Y. Immunization against dental caries.
Vaccine. 2002 May 15;20(16):2027-44.
91. Koga T, Yamashita Y, Nakano Y, Kawasaki M, Oho T, Yu H, et al. Surface proteins
of Streptococcus mutans. Dev Biol Stand. 1995;85:363-9.
92. Kohler B, Andreen I, Jonsson B. The effect of caries-preventive measures in
mothers on dental caries and the oral presence of the bacteria Streptococcus mutans
and lactobacilli in their children. Arch Oral Biol. 1984;29(11):879-83.
93. Koo H. Strategies to enhance the biological effects of fluoride on dental biofilms.
Adv Dent Res. 2008 Jul 1;20(1):17-21.
94. Koo H, Duarte S, Murata RM, Scott-Anne K, Gregoire S, Watson GE, et al.
Influence of cranberry proanthocyanidins on formation of biofilms by Streptococcus
mutans on saliva-coated apatitic surface and on dental caries development in vivo.
Caries Res. 2010;44(2):116-26.
95. Koo H, Hayacibara MF, Schobel BD, Cury JA, Rosalen PL, Park YK, et al. Inhibition
of Streptococcus mutans biofilm accumulation and polysaccharide production by
apigenin and tt-farnesol. J Antimicrob Chemother. 2003 Nov;52(5):782-9.
96. Koo H, Schobel B, Scott-Anne K, Watson G, Bowen WH, Cury JA, et al. Apigenin
and tt-farnesol with fluoride effects on Strep mutans biofilms and dental caries. J Dent
Res. 2005 Nov;84(11):1016-20.

66

97. Koo H, Xiao J, Klein MI, Jeon JG. Exopolysaccharides produced by Streptococcus
mutans glucosyltransferases modulate the establishment of microcolonies within
multispecies biofilms. J Bacteriol. 2010 Jun;192(12):3024-32.
98. Kotake Y, Ishii S, Yano T, Katsuoka Y, Hayashi H. Substrate recognition
mechanism of the peptidase domain of the quorum-sensing-signal-producing ABC
transporter ComA from Streptococcus. Biochemistry. 2008 Feb 26;47(8):2531-8.
99. Krasse B, Edwardsson S, Svensson I, Trell L. Implantation of caries-inducing
streptococci in the human oral cavity. Arch Oral Biol. 1967 Feb;12(2):231-6.
100. Kraus D, Peschel A. Molecular mechanisms of bacterial resistance to antimicrobial
peptides. Curr Top Microbiol Immunol. 2006;306:231-50.
101. Kreth J, Merritt J, Qi F. Bacterial and host interactions of oral streptococci. DNA
Cell Biol. 2009 Aug;28(8):397-403.
102. Kreth J, Merritt J, Shi W, Qi F. Competition and coexistence between
Streptococcus mutans and Streptococcus sanguinis in the dental biofilm. J Bacteriol.
2005 Nov;187(21):7193-203.
103. Kulshrestha S, Khan S, Hasan S, Khan ME, Misba L, Khan AU. Calcium fluoride
nanoparticles induced suppression of Streptococcus mutans biofilm: an in vitro and in
vivo approach. Appl Microbiol Biotechnol. 2015 Nov 27.
104. Kuramitsu HK. Virulence factors of mutans streptococci: role of molecular genetics.
Crit Rev Oral Biol Med. 1993;4(2):159-76.
105. Kurasz AB, Tanzer JM, Bazer L, Savoldi E. In vitro studies of growth and
competition between S. salivarius TOVE-R and mutans streptococci. J Dent Res. 1986
Sep;65(9):1149-53.

67

106. Lamont RJ, Demuth DR, Davis CA, Malamud D, Rosan B. Salivary-agglutininmediated adherence of Streptococcus mutans to early plaque bacteria. Infect Immun.
1991 Oct;59(10):3446-50.
107. Lee CC, Sun Y, Qian S, Huang HW. Transmembrane pores formed by human
antimicrobial peptide LL-37. Biophys J. 2011 Apr 6;100(7):1688-96.
108. Lee JK, Chang SW, Perinpanayagam H, Lim SM, Park YJ, Han SH, et al.
Antibacterial efficacy of a human beta-defensin-3 peptide on multispecies biofilms. J
Endod. 2013 Dec;39(12):1625-9.
109. Leung KP, Crowe TD, Abercrombie JJ, Molina CM, Bradshaw CJ, Jensen CL, et
al. Control of oral biofilm formation by an antimicrobial decapeptide. J Dent Res. 2005
Dec;84(12):1172-7.
110. Leung V, Ajdic D, Koyanagi S, Levesque CM. The formation of Streptococcus
mutans persisters induced by the quorum-sensing peptide pheromone is affected by the
LexA regulator. J Bacteriol. 2015 Mar;197(6):1083-94.
111. Leung V, Dufour D, Levesque CM. Death and survival in Streptococcus mutans:
differing outcomes of a quorum-sensing signaling peptide. Front Microbiol. 2015 Oct
23;6:1176.
112. Leung V, Levesque CM. A stress-inducible quorum-sensing peptide mediates the
formation of persister cells with noninherited multidrug tolerance. J Bacteriol. 2012
May;194(9):2265-74.
113. Li F, Michalek SM, Dasanayake AP, Li Y, Kirk K, Childers NK. Intranasal
immunization of humans with Streptococcus mutans antigens. Oral Microbiol Immunol.
2003 Oct;18(5):271-7.

68

114. Li H, Cheng JW, Yu HY, Xin Y, Tang L, Ma Y. Effect of the antimicrobial peptide DNal-Pac-525 on the growth of Streptococcus mutans and its biofilm formation. J
Microbiol Biotechnol. 2013 Aug;23(8):1070-5.
115. Li LN, Guo LH, Lux R, Eckert R, Yarbrough D, He J, et al. Targeted antimicrobial
therapy against Streptococcus mutans establishes protective non-cariogenic oral
biofilms and reduces subsequent infection. Int J Oral Sci. 2010 Jun;2(2):66-73.
116. Li XS, Sun JN, Okamoto-Shibayama K, Edgerton M. Candida albicans cell wall ssa
proteins bind and facilitate import of salivary histatin 5 required for toxicity. J Biol Chem.
2006 Aug 11;281(32):22453-63.
117. Li YH, Tian XL, Layton G, Norgaard C, Sisson G. Additive attenuation of virulence
and cariogenic potential of Streptococcus mutans by simultaneous inactivation of the
ComCDE quorum-sensing system and HK/RR11 two-component regulatory system.
Microbiology. 2008 Nov;154(Pt 11):3256-65.
118. Liljemark WF, Bloomquist C. Human oral microbial ecology and dental caries and
periodontal diseases. Crit Rev Oral Biol Med. 1996;7(2):180-98.
119. Liu Y, Wang L, Zhou X, Hu S, Zhang S, Wu H. Effect of the antimicrobial
decapeptide KSL on the growth of oral pathogens and Streptococcus mutans biofilm. Int
J Antimicrob Agents. 2011 Jan;37(1):33-8.
120. Lobene RR. 2. A clinical study of the effect of dextranase on human dental plaque.
J Am Dent Assoc. 1971 Jan;82(1):132-5.
121. Loesche WJ. Role of Streptococcus mutans in human dental decay. Microbiol Rev.
1986 Dec;50(4):353-80.

69

122. Loesche WJ, Rowan J, Straffon LH, Loos PJ. Association of Streptococcus
mutants with human dental decay. Infect Immun. 1975 Jun;11(6):1252-60.
123. Lonn-Stensrud J, Petersen FC, Benneche T, Scheie AA. Synthetic bromated
furanone inhibits autoinducer-2-mediated communication and biofilm formation in oral
streptococci. Oral Microbiol Immunol. 2007 Oct;22(5):340-6.
124. Ma JK, Lehner T. Prevention of colonization of Streptococcus mutans by topical
application of monoclonal antibodies in human subjects. Arch Oral Biol. 1990;35
Suppl:115S-22S.
125. Mah TF. Biofilm-specific antibiotic resistance. Future Microbiol. 2012
Sep;7(9):1061-72.
126. Mah TF, O'Toole GA. Mechanisms of biofilm resistance to antimicrobial agents.
Trends Microbiol. 2001 Jan;9(1):34-9.
127. Marchisio O, Esposito MR, Genovesi A. Salivary pH level and bacterial plaque
evaluation in orthodontic patients treated with Recaldent products. Int J Dent Hyg. 2010
Aug;8(3):232-6.
128. Marquis RE. Antimicrobial actions of fluoride for oral bacteria. Can J Microbiol.
1995 Nov;41(11):955-64.
129. Marquis RE, Clock SA, Mota-Meira M. Fluoride and organic weak acids as
modulators of microbial physiology. FEMS Microbiol Rev. 2003 Jan;26(5):493-510.
130. Marsh PD. Controlling the oral biofilm with antimicrobials. J Dent. 2010 Jun;38
Suppl 1:S11-5.
131. Marsh PD. Microbiology of dental plaque biofilms and their role in oral health and
caries. Dent Clin North Am. 2010 Jul;54(3):441-54.

70

132. Marsh PD. Dental plaque as a biofilm: the significance of pH in health and caries.
Compend Contin Educ Dent. 2009 Mar;30(2):76,8, 80, 83-7; quiz 88, 90.
133. Marsh PD. Dental plaque as a biofilm and a microbial community - implications for
health and disease. BMC Oral Health. 2006 Jun 15;6 Suppl 1:S14.
134. Marsh PD, Head DA, Devine DA. Ecological approaches to oral biofilms: control
without killing. Caries Res. 2015;49 Suppl 1:46-54.
135. Mattos-Graner RO, Correa MS, Latorre MR, Peres RC, Mayer MP. Mutans
streptococci oral colonization in 12-30-month-old Brazilian children over a one-year
follow-up period. J Public Health Dent. 2001 Summer;61(3):161-7.
136. McGhee, Michalek SM, Webb J, Navia JM, Rahman AF, Legler DW. Effective
immunity to dental caries: protection of gnotobiotic rats by local immunization with
Streptococcus mutans. J Immunol. 1975 Jan;114(1 Pt 2):300-5.
137. Merritt J, Qi F, Goodman SD, Anderson MH, Shi W. Mutation of luxS affects biofilm
formation in Streptococcus mutans. Infect Immun. 2003 Apr;71(4):1972-9.
138. Milgrom P, Zero DT, Tanzer JM. An examination of the advances in science and
technology of prevention of tooth decay in young children since the Surgeon General's
Report on Oral Health. Acad Pediatr. 2009 Nov-Dec;9(6):404-9.
139. Mitchell TJ. The pathogenesis of streptococcal infections: from tooth decay to
meningitis. Nat Rev Microbiol. 2003 Dec;1(3):219-30.
140. Morones JR, Elechiguerra JL, Camacho A, Holt K, Kouri JB, Ramirez JT, et al. The
bactericidal effect of silver nanoparticles. Nanotechnology. 2005 Oct;16(10):2346-53.
141. Nakatsuji T, Gallo RL. Antimicrobial peptides: old molecules with new ideas. J
Invest Dermatol. 2012 Mar;132(3 Pt 2):887-95.

71

142. Nyvad B. Microbial colonization of human tooth surfaces. APMIS Suppl. 1993;32:145.
143. Otto M. Bacterial evasion of antimicrobial peptides by biofilm formation. Curr Top
Microbiol Immunol. 2006;306:251-8.
144. Peng JJ, Botelho MG, Matinlinna JP. Silver compounds used in dentistry for caries
management: a review. J Dent. 2012 Jul;40(7):531-41.
145. Petersen FC, Tao L, Scheie AA. DNA binding-uptake system: a link between cellto-cell communication and biofilm formation. J Bacteriol. 2005 Jul;187(13):4392-400.
146. Petersen PE. Global policy for improvement of oral health in the 21st century-implications to oral health research of World Health Assembly 2007, World Health
Organization. Community Dent Oral Epidemiol. 2009 Feb;37(1):1-8.
147. Petersen PE, Bourgeois D, Ogawa H, Estupinan-Day S, Ndiaye C. The global
burden of oral diseases and risks to oral health. Bull World Health Organ. 2005
Sep;83(9):661-9.
148. Pinar Erdem A, Sepet E, Kulekci G, Trosola SC, Guven Y. Effects of two fluoride
varnishes and one fluoride/chlorhexidine varnish on Streptococcus mutans and
Streptococcus sobrinus biofilm formation in vitro. Int J Med Sci. 2012;9(2):129-36.
149. Plotkin SA. Correlates of protection induced by vaccination. Clin Vaccine Immunol.
2010 Jul;17(7):1055-65.
150. Pratten J, Barnett P, Wilson M. Composition and susceptibility to chlorhexidine of
multispecies biofilms of oral bacteria. Appl Environ Microbiol. 1998 Sep;64(9):3515-9.

72

151. Ramazanzadeh B, Jahanbin A, Yaghoubi M, Shahtahmassbi N, Ghazvini K,
Shakeri M, et al. Comparison of Antibacterial Effects of ZnO and CuO Nanoparticles
Coated Brackets against Streptococcus Mutans. J Dent (Shiraz). 2015 Sep;16(3):200-5.
152. Remis JP, Costerton JW, Auer M. Biofilms: structures that may facilitate cell-cell
interactions. ISME J. 2010 Sep;4(9):1085-7.
153. Ren Z, Cui T, Zeng J, Chen L, Zhang W, Xu X, et al. Molecule Targeting
Glucosyltransferase Inhibits Streptococcus mutans Biofilm Formation and Virulence.
Antimicrob Agents Chemother. 2015 Oct 19;60(1):126-35.
154. Rosan B, Lamont RJ. Dental plaque formation. Microbes Infect. 2000
Nov;2(13):1599-607.
155. Rosenblatt A, Stamford TC, Niederman R. Silver diamine fluoride: a caries "silverfluoride bullet". J Dent Res. 2009 Feb;88(2):116-25.
156. Ruangsri P, Orstavik D. Effect of the acquired pellicle and of dental plaque on the
implantation of Streptococcus mutans on tooth surfaces in man. Caries Res.
1977;11(4):204-10.
157. Russell MW, Hajishengallis G, Childers NK, Michalek SM. Secretory immunity in
defense against cariogenic mutans streptococci. Caries Res. 1999;33(1):4-15.
158. Sakanaka S. Antibacterial substances in Japanese green tea extract
against Streptococcus mutans, a cariogenic bacterium. Agric Biol Chem. 1989;53:23072311.
159. Santos VE,Jr, Vasconcelos Filho A, Targino AG, Flores MA, Galembeck A, Caldas
AF,Jr, et al. A new "silver-bullet" to treat caries in children--nano silver fluoride: a
randomised clinical trial. J Dent. 2014 Aug;42(8):945-51.

73

160. Savas S, Kucukyilmaz E, Celik EU, Ates M. Effects of different antibacterial agents
on enamel in a biofilm caries model. J Oral Sci. 2015;57(4):367-72.
161. Savas S, Kucukyilmaz E, U Celik E, Ates M. Effects of different antibacterial
agents on enamel in a biofilm caries model. J Oral Sci. 2015;57(4):367-72.
162. Schmidt NW, Mishra A, Lai GH, Davis M, Sanders LK, Tran D, et al. Criterion for
amino acid composition of defensins and antimicrobial peptides based on geometry of
membrane destabilization. J Am Chem Soc. 2011 May 4;133(17):6720-7.
163. Seo MD, Won HS, Kim JH, Mishig-Ochir T, Lee BJ. Antimicrobial peptides for
therapeutic applications: a review. Molecules. 2012 Oct 18;17(10):12276-86.
164. Shang D, Liang H, Wei S, Yan X, Yang Q, Sun Y. Effects of antimicrobial peptide
L-K6, a temporin-1CEb analog on oral pathogen growth, Streptococcus mutans biofilm
formation, and anti-inflammatory activity. Appl Microbiol Biotechnol. 2014
Oct;98(20):8685-95.
165. Shapiro S, Meier A, Guggenheim B. The antimicrobial activity of essential oils and
essential oil components towards oral bacteria. Oral Microbiol Immunol. 1994
Aug;9(4):202-8.
166. Shi W, Li YH, Liu F, Yang JY, Zhou DH, Chen YQ, et al. Flagellin enhances saliva
IgA response and protection of anti-caries DNA vaccine. J Dent Res. 2012
Mar;91(3):249-54.
167. Smith DJ. Dental caries vaccines: prospects and concerns. Crit Rev Oral Biol Med.
2002;13(4):335-49.

74

168. Smith DJ, King WF, Godiska R. Passive transfer of immunoglobulin Y antibody to
Streptococcus mutans glucan binding protein B can confer protection against
experimental dental caries. Infect Immun. 2001 May;69(5):3135-42.
169. Smith DJ, King WF, Rivero J, Taubman MA. Immunological and protective effects
of diepitopic subunit dental caries vaccines. Infect Immun. 2005 May;73(5):2797-804.
170. Smith DJ, Lam A, Barnes LA, King WF, Peacock Z, Wise DL, et al. Remote
glucosyltransferase-microparticle vaccine delivery induces protective immunity in the
oral cavity. Oral Microbiol Immunol. 2003 Aug;18(4):240-8.
171. Smith DJ, Taubman MA. Experimental immunization of rats with a Streptococcus
mutans 59-kilodalton glucan-binding protein protects against dental caries. Infect
Immun. 1996 Aug;64(8):3069-73.
172. Smith DJ, Taubman MA. Effect of local deposition of antigen on salivary immune
responses and reaccumulation of mutans streptococci. J Clin Immunol. 1990
Sep;10(5):273-81.
173. Smith DJ, Taubman MA. Oral immunization of humans with Streptococcus
sobrinus glucosyltransferase. Infect Immun. 1987 Nov;55(11):2562-9.
174. Smith DJ, Taubman MA, Ebersole JL. Effects of local immunization with
glucosyltransferase fractions from Streptococcus mutans on dental caries in hamsters
caused by homologous and heterologous serotypes of Streptococcus mutans. Infect
Immun. 1978 Sep;21(3):843-51.
175. Song F, Koo H, Ren D. Effects of Material Properties on Bacterial Adhesion and
Biofilm Formation. J Dent Res. 2015 Aug;94(8):1027-34.

75

176. Song L, Zhang Y, Yun NE, Poussard AL, Smith JN, Smith JK, et al. Superior
efficacy of a recombinant flagellin:H5N1 HA globular head vaccine is determined by the
placement of the globular head within flagellin. Vaccine. 2009 Sep 25;27(42):5875-84.
177. Stephan RM. Intra-oral hydrogen-ion concentration associated with dental caries
activity. J Dent Res. 1944;23:257-266.
178. Stephan RM. Two Factors of Possible Importance in Relation to the Etiology and
Treatment of Dental Caries and Other Dental Diseases. Science. 1940 Dec
20;92(2399):578-9.
179. Sullivan R, Santarpia P, Lavender S, Gittins E, Liu Z, Anderson MH, et al. Clinical
efficacy of a specifically targeted antimicrobial peptide mouth rinse: targeted elimination
of Streptococcus mutans and prevention of demineralization. Caries Res.
2011;45(5):415-28.
180. Sun JH, Niu YM, Fan MW, Xu QA, Yang XC. Protective efficacy of a new fusion
anti-caries DNA vaccine encoding antigens of both Streptococcus mutans and
Streptococcus sobrinus. Zhonghua Yi Xue Za Zhi. 2009 Aug 25;89(32):2286-91.
181. Sun JH, Xu QA, Fan MW. A new strategy for the replacement therapy of dental
caries. Med Hypotheses. 2009 Dec;73(6):1063-4.
182. Svanberg M, Krasse B. Oral implantation of saliva-treated Streptococcus mutans in
man. Arch Oral Biol. 1981;26(3):197-201.
183. Syvitski RT, Tian XL, Sampara K, Salman A, Lee SF, Jakeman DL, et al.
Structure-activity analysis of quorum-sensing signaling peptides from Streptococcus
mutans. J Bacteriol. 2007 Feb;189(4):1441-50.

76

184. Tagg JR, Dierksen KP. Bacterial replacement therapy: adapting 'germ warfare' to
infection prevention. Trends Biotechnol. 2003 May;21(5):217-23.
185. Talbman MA, Smith DJ. Effects of local immunization with Streptococcus mutans
on induction of salivary immunoglobulin A antibody and experimental dental caries in
rats. Infect Immun. 1974 Jun;9(6):1079-91.
186. Targino AG, Flores MA, dos Santos Junior VE, de Godoy Bene Bezerra F, de Luna
Freire H, Galembeck A, et al. An innovative approach to treating dental decay in
children. A new anti-caries agent. J Mater Sci Mater Med. 2014 Aug;25(8):2041-7.
187. Taubman MA, Smith DJ. Oral immunization for the prevention of dental diseases.
Curr Top Microbiol Immunol. 1989;146:187-95.
188. Taylor DN, Treanor JJ, Strout C, Johnson C, Fitzgerald T, Kavita U, et al. Induction
of a potent immune response in the elderly using the TLR-5 agonist, flagellin, with a
recombinant hemagglutinin influenza-flagellin fusion vaccine (VAX125, STF2.HA1 SI).
Vaccine. 2011 Jul 12;29(31):4897-902.
189. Tong H, Chen W, Merritt J, Qi F, Shi W, Dong X. Streptococcus oligofermentans
inhibits Streptococcus mutans through conversion of lactic acid into inhibitory H2O2: a
possible counteroffensive strategy for interspecies competition. Mol Microbiol. 2007
Feb;63(3):872-80.
190. Treanor JJ, Taylor DN, Tussey L, Hay C, Nolan C, Fitzgerald T, et al. Safety and
immunogenicity of a recombinant hemagglutinin influenza-flagellin fusion vaccine
(VAX125) in healthy young adults. Vaccine. 2010 Dec 6;28(52):8268-74.
191. van Houte J. Role of micro-organisms in caries etiology. J Dent Res. 1994
Mar;73(3):672-81.

77

192. Vargas CM, Crall JJ, Schneider DA. Sociodemographic distribution of pediatric
dental caries: NHANES III, 1988-1994. J Am Dent Assoc. 1998 Sep;129(9):1229-38.
193. Vitkov L, Hermann A, Krautgartner WD, Herrmann M, Fuchs K, Klappacher M, et
al. Chlorhexidine-induced ultrastructural alterations in oral biofilm. Microsc Res Tech.
2005 Oct;68(2):85-9.
194. Vollmer WM, Papas AS, Bader JD, Maupome G, Gullion CM, Hollis JF, et al.
Design of the Prevention of Adult Caries Study (PACS): a randomized clinical trial
assessing the effect of a chlorhexidine dental coating for the prevention of adult caries.
BMC Oral Health. 2010 Oct 5;10:23,6831-10-23.
195. Wachsmann D, Klein JP, Scholler M, Ogier J, Ackermans F, Frank RM. Serum and
salivary antibody responses in rats orally immunized with Streptococcus mutans
carbohydrate protein conjugate associated with liposomes. Infect Immun. 1986
May;52(2):408-13.
196. Wang BY, Kuramitsu HK. Interactions between oral bacteria: inhibition of
Streptococcus mutans bacteriocin production by Streptococcus gordonii. Appl Environ
Microbiol. 2005 Jan;71(1):354-62.
197. Wang Z, de la Fuente-Nunez C, Shen Y, Haapasalo M, Hancock RE. Treatment of
Oral Multispecies Biofilms by an Anti-Biofilm Peptide. PLoS One. 2015 Jul
13;10(7):e0132512.
198. Weinberg ED. Suppression of bacterial biofilm formation by iron limitation. Med
Hypotheses. 2004;63(5):863-5.

78

199. Wijeyeweera RL, Kleinberg I. Arginolytic and ureolytic activities of pure cultures of
human oral bacteria and their effects on the pH response of salivary sediment and
dental plaque in vitro. Arch Oral Biol. 1989;34(1):43-53.
200. Wolcott R, Costerton JW, Raoult D, Cutler SJ. The polymicrobial nature of biofilm
infection. Clin Microbiol Infect. 2013 Feb;19(2):107-12.
201. Wong MC, Lo EC, Schwarz E, Zhang HG. Oral health status and oral health
behaviors in Chinese Children. J Dent Res. 2001 May;80(5):1459-65.
202. Xu QA, Yu F, Fan MW, Bian Z, Chen Z, Peng B, et al. Protective efficacy of a
targeted anti-caries DNA plasmid against cariogenic bacteria infections. Vaccine. 2007
Jan 26;25(7):1191-5.
203. Yang J, Zhong M, Zhang Y, Zhang E, Sun Y, Cao Y, et al. Antigen replacement of
domains D2 and D3 in flagellin promotes mucosal IgA production and attenuates
flagellin-induced inflammatory response after intranasal immunization. Hum Vaccin
Immunother. 2013 May;9(5):1084-92.
204. Yang L, Liu Y, Wu H, Hoiby N, Molin S, Song ZJ. Current understanding of multispecies biofilms. Int J Oral Sci. 2011 Apr;3(2):74-81.
205. Yoshida A, Ansai T, Takehara T, Kuramitsu HK. LuxS-based signaling affects
Streptococcus mutans biofilm formation. Appl Environ Microbiol. 2005 May;71(5):237280.
206. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature. 2002 Jan
24;415(6870):389-95.

79

207. Zaura-Arite E, van Marle J, ten Cate JM. Conofocal microscopy study of
undisturbed and chlorhexidine-treated dental biofilm. J Dent Res. 2001 May;80(5):143640.
208. Zhang K, Ou M, Wang W, Ling J. Effects of quorum sensing on cell viability in
Streptococcus mutans biofilm formation. Biochem Biophys Res Commun. 2009 Feb
20;379(4):933-8.

80

